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Many Gram-negative bacterial pathogens utilize type III secretion systems 
(TTSSs) for subverting the normal cellular functions of their target eukaryotic cells. 
The type III secretion apparatus (TTSA) functions like a syringe to inject proteins 
through an external needle and into a target cell’s membrane and cytosol. The TTSA 
basal body spans the bacterial inner and outer membranes, and the external needle is 
topped with a tip complex that controls the secretion and delivery of translocator and 
effector proteins. The needle is formed by the polymerization of ~120 copies of a 
small acidic protein that is conserved among diverse pathogens. At the tip of the 
needle, a tip complex is assembled by tip proteins into a ring-like structure which 
serves as a platform for the assembly of the translocon by translocator proteins. We 
use NMR spectroscopy to understand how the needle is assembled and how the tip 
complex is assembled on top of the needle. We determined the solution structures of 
the BsaL needle monomer from Burkholderia pseudomallei and the PrgI needle 
monomer from Salmonella typhimurium. We characterized PrgI monomer-monomer 
interaction using NMR chemical shift mapping; and multiple contacts were found to 
be involved in Salmonella needle assembly. The tip complex is assembled by SipD, 
the tip protein in Salmonella, and BipD, the tip protein in Burkholderia. We also 
characterized PrgI-SipD and BipD-BsaL interactions by NMR. Despite weak binding 
affinities we learned that distinct binding sites of PrgI were involved in the PrgI-PrgI 
and PrgI-SipD interactions. Tip proteins were also reported to interact with 
iv 
deoxycholate (DOC), a small molecule component of bile acids. We also 
characterized the SipD-DOC interactions by NMR. Based on data described in this 
dissertation, we conclude that electrostatic contacts are important in needle assembly 
and needle-packing interactions may be different among these bacteria. With respect 
to PrgI the binding sites involved in the PrgI-PrgI and PrgI-SipD interactions are also 
distinct. In addition, SipD-PrgI and SipD-DOC interactions provide valuable 
structural information to understand the activation mechanism of type III secretion.  
The hantaviruses are emerging infectious viruses that in humans can cause a 
cardiopulmonary syndrome or a hemorrhagic fever with renal syndrome. The 
nucleocapsid (N) is the most abundant viral protein, and during viral assembly, the N 
protein forms trimers and packages the viral RNA genome. We determined the NMR 
structure of the N-terminal domain (residues 1–74, called N1–74) of the Andes 
hantavirus N protein. N1–74 forms two long helices (α1 and α2) that intertwine into a 
coiled coil domain. The conserved hydrophobic residues at the helix α1-α2 interface 
stabilize the coiled coil; however, there are many conserved surface residues whose 
function is not known. Site-directed mutagenesis, CD spectroscopy, and 
immunocytochemistry reveal that a point mutation in the conserved basic surface 
formed by Arg22 or Lys26 lead to antibody recognition based on the subcellular 
localization of the N protein. Thus, Arg22 and Lys26 are likely involved in a 
conformational change or molecular recognition when the N protein is trafficked from 
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Chapter 1: Introduction of the Type III Secretion Apparatus 
 
THE TYPE III SECRETION SYSTEM 
 A common critical virulence factor for numerous Gram-negative bacterial 
pathogens in humans, animals and plants is the type III secretion system (TTSS).1; 2; 3; 
4 Among these bacteria are human pathogens such as enteropathogenic Escherichia 
coli (EPEC), Salmonella spp., Yersinia spp., Shigella spp., Burkholderia spp., and 
Pseudomonas aeruginosa. Illnesses caused by these pathogens range from 
opportunistic lung infections by P. aeruginosa to gastroenteritis caused by 
Salmonella typhimurium, Shigella pestis and Yersinia enterocolitica, to 
overwhelming systemic infections by Yersinia pestis, Salmonella typhi, and 
Burkholderia pseudomallei.1; 2 More commonly, Salmonella typhimurium still elicit 
public health attention due to the recent outbreaks of human infections and food 
product recalls (www.cdc.gov). Burkholderia and Yersinia are considered serious 
bioterrorism threats and  as CDC and USDA Select Agents.5 In all cases, TTSS 
contributes to infection by allowing prokaryote communication with eukaryotic cells.2 
The outcome of this interspecies communication varies with pathogens and host cell 
types.2 Nevertheless, these bacteria use TTSS for subverting normal cellular functions 
of their target eukaryotic cell and thereby most likely to cause infectious diseases.1  
No vaccines are currently approved for general use against most of these pathogens.6; 
7; 8; 9 Together with the appearance of antibiotic resistant strains and the bioterrorism 
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potential of Burkholderia and Yersinia, these pathogens continue to pose major public 
health and safety concerns.5; 10 
In Salmonella, TTSS-dependent invasion, survival, and persistence of 
pathogens within target cells are associated with damage to host tissues.1; 11 TTSS-
associated damage of host cells takes different forms, including direct cytotoxicity 
associated with the induction of apoptosis or necrosis or tissue damage associated 
with the disruption of tissue barriers.11; 12; 13; 14; 15; 16 These mechanisms directly result 
in pathological outcomes, such as diarrhea, inflammation and more severe systemic 
infection.17; 18  
The type III secretion system is composed of multiple protein components, 
which includes the type III secretion apparatus (structural proteins), translocators 
(structural proteins), chaperones, effector proteins and regulators (Fig. 1-1). These 
proteins work coordinately to fulfill the protein secretion function from the bacterial 
cell into the attached host cell.19 TTSS genes are encoded on pathogenicity islands 
(PAIs) which have distinct G/C content compared with the adjacent DNA 
sequence.20; 21 Within these islands, the loci organization is very similar among 
different bacterial species.20; 21 However, different gene products share different 
levels of similarity, implying a divergence in evolution.20; 21; 22 
While inside the bacterial cytosol, TTSS chaperonees bind specific pre-
synthesized translocators and effector proteins and maintain the proteins in a 
secretion-competent state.23; 24 The synthesis and secretion of late effector proteins are 




Figure 1-1. The type III secretion system (TTSS) consists of the secretion apparatus, 
chaperones, and effector proteins. The type III secretion apparatus (TTSA) provides a 
conduit for the passage of effector proteins into the cytosol of the target cell.27  
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contact, the bacterial secretion is fully activated and a subgroup of proteins is 
subsequently secreted in seconds.28; 29 The protein is secreted in a very specific order, 
and it is believed that the secreted proteins are in a partially unfolded state.30; 31; 32 The 
first secreted proteins are translocators that attach to the host cell membrane and form 
the translocon pore.33; 34 The effector proteins can enter the host cell through the pore 
and mimic the host proteins to manipulate the host cellular function for the 
bacterium’s benefit.18; 35 These secreted translocators and effector proteins adopt 
unconserved functions and reflect host and tissue specificity.36 In both Salmonella 
and Shigella,  the effector proteins interact with host proteins and induce cytoskeletal 
rearrangments, which result in membrane ruffling that facilitates bacterial uptake, 
secretion of pro-inflammatory cytokines, death of macrophages or alterations in 
vesicle trafficking pathways inside the host cell (Fig. 1-2).11; 18  
 
THE TYPE III SECRETION APPARATUS 
The protein transport from a Gram-negative bacterial cell to the host cell by 
TTSS is powered and mediated by a specific secretion apparatus, the type III 
secretion apparatus (TTSA). TTSA is a macromolecular protein assembly that allows 
physical contact between the pathogen and its target cell.1 TTSA is a complex 
protein-secretion nanomachine used to deliver bacterial effector proteins directly into 
target eukaryotic host cells’ membrane and cytosol. These effectors then display a 
variety of pathogen-specific roles that alter normal host cell regulatory events.18 






Figure 1-2. Salmonella uptake by human epithelial cell. Color-enhanced scanning 
electron micrograph showing Salmonella typhimurium (red) invading cultured human 
cells. (Fig. 1-2 is adapted from Rocky Mountain Laboratories, NIAID, NIH) 
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multi-protein assembly for this translocating process, is structurally and functionally 
conserved.32 TTSA was first visualized by transmission electron microscopy (Fig. 1-
3), and it resembles a syringe and needle (Fig. 1-1).37 TTSA is assembled from more 
than 20 different proteins, most of which are associated with the bacterial inner 
membrane, which anchors the apparatus and provides the energy needed for the 
translocation of later structural units, translocator proteins and effectors in an ATP-
dependent manner.19 TTSA is composed of three major parts: the basal body, the 
external needle and a tip complex at the tip of the needle (Fig. 1-1).37 The entire basal 
body spans the bacterial inner membrane, the peptidoglycan layer and outer 
membrane with the three most abundant components forming the inner and outer 
membrane rings.11; 37 The extracellular portion of TTSA consists of a needle and a tip 
complex that controls secretion.38  
 
THE TYPE III SECRETION NEEDLE 
A prominent feature of TTSA is the existence of an external needle formed by 
the assembly of a single type of protein, the needle protein (Fig. 1-3).39 The proper 
assembly of the needle is critical in bacterial pathogenesis in Shigella and 
Salmonella.38; 40; 41 Analogous to a bacterial flagellum, it is believed that needle 
monomers pass through the channel and polymerize at the growing distal end of the 
needle.32 Needle proteins are critical for bacterial virulence as needle protein null 
mutants are non-invasive.38; 40; 41 Additionally, needle proteins are suggested to 





Figure 1-3. (A) Electron micrographs of osmotically shocked nonflagellated ΔflhC S. 
typhimurium which exhibits needle complexes on the bacterial envelope (open 
arrows).37 (B) Needle complexes isolated obtained from an enriched fraction of the 
CsCl density gradient from S. typhimurium ΔflhC.37 Scale bar, 100nm. (C) Various 
views of the three-dimensional reconstruction of Shigella flexneri Needle, showing 
the top view, side view and composite image for the structure of the needle complex 
in both the bacterial inner and outer membranes.39 (Fig. 1-3A and 1-3B are from Ref. 
37; Fig. 1-3C is from Ref. 38.) 
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that the bacterial needle mediated the transmission of the invasion signal from the 
outside environment into the bacterium.42 However, detailed understanding of how 
the needle is assembled and how proteins travel through the needle is still not clear.  
 
THE TYPE III SECRETION TIP COMPLEX 
Bacterial translocator proteins are delivered directly into the host cell 
membrane to form a translocon pore through which effector proteins are then 
translocated into the host cytoplasm.32 This process is mediated by a protein complex 
at the tip of the TTSA needle, and appropriately named tip complex.24 The tip protein 
LcrV, which is also called the V-antigen of Yersinia, was first visualized and found to 
assemble into a ring-like structure at the tip of the Y. enterocolitica needle.43 It is 
believed that the tip complex serves as a platform for the assembly of the translocon, 
which ultimately connects the bacterial pathogen to its eukaryotic host.2 Tip proteins 
are important for bacterial type III secretion since tip proteins mutants, e.g. SipD (in 
Salmonella), IpaD (in Shigella) and BipD (in Burkholderia), showed reduced 
invasiveness in their respective organisms.44; 45; 46 Although the precise sensing and 
triggering mechanisms of type III secretion through the tip complex are currently 
unknown, it is clear that direct contact between TTSA and some component of the 
host cell membrane leads to induction of type III secretion in vivo.47 Environment-
mediated secretion by the tip compelx is further transduced from the tip to the basal 
body through subtle conformation changes of needle packing.42 In summary, the type 
III secretion apparatus (TTSA) not only controls protein transport, but also mediates 
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the transmission of secretion signals into the bacterium. Because the type III secretion 
needle apparatus is surface-exposed and critical for bacterial virulence, disrupting this 
protein assembly is an attractive target for the development of novel anti-bacterial 
agents that will prevent infection. 
 
CONCLUSION 
The increasing number of atomic structures of TTSA components have 
provided abundant information for understanding this complex nanomachinery.2 
Individual structures of protein components alone, however, do not answer several 
outstanding questions, namely: (i) how needle and tip complex are assembled, (ii) 
how the tip complex recognizes extracellular signals, (iii) how the invasion signal is 
transmitted to the TTSA base, and (iv) how the tip complex interacts with the nascent 
translocator proteins. More detailed understanding of protein-protein interactions and 
protein dynamics involved in TTSA assembly and function require a combinantion of 
molecular, structural and biophysical techniques. All the valuable knowledge 
obtained through such studies could be exploited in developing novel drugs targeted 
against bacterial virulence. 
This dissertation mainly focuses on the characterization of the protein 
structures and protein-protein interactions involved in the assembly of the Salmonella 
needle and tip complex. New knowledge gained in this bacterium can be further 
extended to other bacterial type III secretion systems. Research in this dissertation has 
contributed toward understanding needle assembly by determining the atomic 
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structures of two needle monomers, BsaL and PrgI. I helped solving the first atomic 
structure of needle protein, the solution structure of monomeric BsaL, which is 
described in chapter 2 (adapted from a published paper by Lingling Zhang et al. 2006, 
J. Mol. Biol.).48 In chapter 3, the solution structure of PrgI, the needle protein of 
Salmonella (adapted from a published paper by Yu Wang et al. 2007, J. Mol. Biol.) is 
described.27 In chapter 4, the protein-protein interaction involved in the Salmonella 
needle assembly is described. In chapter 5, needle-tip and tip-deoxycholate 
interactions are described. Additional contents in the dissertation from chapter 1 to 
chapter 5 were adapted from a review paper by Yu Wang et al. (Reproduced by 
permission of The Royal Society of Chemistry).2 
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A major component of TTSA is an external needle that extends from a basal 
structure and forms a conduit for translocating proteins into the target cell.1 For S. 
typhimurium, TTSA needle is formed by the assembly of multiple copies of a single 
protein, PrgI, which is a homolog of MxiH in Shigella, BsaL in Burkholderia, YscF 
in Yersinia and PscF in Pseudomonas. Numerous studies have been done in Shigella 
flexneri and the exposed needle on the Shigella surface consists of a tube-like 
structure with a 70 Å outer diameter and a 25 Å inner diameter channel that extends 
500 Å from the base of TTSA (Fig. 1-3).2; 3 A similar structure exists at the surface of 
Salmonella,4 Yersinia5and Pseudomonas aeruginosa.6 Computer reconstruction of 
low-resolution electron microscopy images from the needles of Shigella flexneri 
shows that the approximately 120 needle monomers polymerize in a helical fashion, 
with 5.6 subunits per turn and a 24 Å helical pitch.2; 3; 4  
Mutational analysis has implicated MxiH in participating in control of type III 
secretion induction in Shigella 7 with related findings reported for YscF of Yersinia 
pestis.8 Needle proteins are critical in bacterial virulence since mxiH 9 and prgI 10 null 
mutants are non-invasive and do not secrete any effectors. These reports implicate 
TTSA needle and any associated extracellular proteins in sensing host cell contact 
and the transmission of type III secretion signals.11; 12 
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Sequence alignments of the needle proteins from various bacterial species 
show higher sequence conservation in the middle part of the proteins compared to 
their amino-termini (Fig. 2-1). Most of the needle proteins adopt a PxxP motif in the 
middle (Fig. 2-1). Secondary structure predictions indicate a predominantly α-helical 
secondary content with some possible β-strand structure.7; 13 Circular dichroism (CD) 
spectroscopy confirms the α-helical content of the Shigella needle protein MxiH,13 as 
well as PrgI13 and BsaL14. Because of the potential of needle monomer for self-
association (R. Kenjale et al., unpublished results), handling recombinant needle 
proteins in vitro must be considered in such studies. Previous studies have shown that 
short C-terminal deletions render at least some TTSA needle proteins unable to 
polymerize on the bacterial surface.7 Such deletions yielded soluble forms of MxiH13, 
PrgI13 and BsaL (R. Kenjale et al., unpublished). These needle protein monomers 
retain all of their native secondary structure and tend to display readily reversible 
thermal unfolding.13 
B. pseudomallei is the causative agent of mellioidosis, an illness that can 
manifest itself in humans as an acute, sub-acute or chronic infection.15 Infection by 
this saprophytic bacterium is endemic to southeast Asia and northern Australia and 
has the potential for global spread.15 Acute mellioidosis is a potentially fatal 
septicemic infection, while the sub-acute form of the disease can lead to the formation 
of systemic abscesses in multiple organ systems.16 Asymptomatic infections can 
progress to clinical mellioidosis as is often observed in endemic regions.17 Acute and 







Figure 2-1. TTSS needle proteins of different bacteria show sequence conservation, 
especially within the core structure where helix α1 and α2 of BsaL are located. The 
conserved P-(S/D)-(D/N)-P motif that forms the inter-helical turn in BsaL is boxed. 
The residues at the interface of the BsaL helix α1 and α2, which are involved in 
stabilizing the structure of the core domain, are also conserved among bacterial 
species (also boxed). Conserved and identical residues are in blue, and the glycine 
and proline residues preceding helix α1, are in red. Sequences are from Swiss-Prot, 
and the bacterial species and its associated needle protein are: B. pseudomallei 
(BsaL), S. flexneri (MxiH), S. typhimurium (PrgI), E. coli O157:H7 (EprI), Y. pestis 
(YscF), and P. aeruginosa (PscF).14 
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for delayed, and often fatal, relapse 16 despite appropriate antibiotic therapy during 
the initial infection.18 B. pseudomallei and its close relative Burkholderia mallei 
(causative agent of glanders) are considered important bioterrorism agents due to 
their ready world-wide availability and their ability to be transmitted by aerosol.19 B. 
pseudomallei possesses at least one genetic region that encodes a TTSS, resembling 
that of the plant pathogens Ralstonia solanacearum and Xanthomonas spp.19 A 
separate TTSS (the bsa locus) encoded within a recently identified B. pseudomallei 
pathogenicity island 19 is similar to those encoded by the Shigella virulence plasmid 
(the Mxi/Spa TTSS) and Salmonella pathogenicity island SPI-1 (Inv/Spa TTSS).19 
These genetic elements encode proteins such as invasins (Inv), membrane excretion 
of invasins (Mxi), and surface presentation of antigens (Spa), required by Shigella 
and Salmonella to become virulent. The importance of the Bsa TTSS for B. 
pseudomallei virulence and pathogenesis is not yet entirely clear; however, it has 
been predicted that cellular invasion and survival in macrophages is an important 
aspect of B. pseudomallei pathogenesis.20 Furthermore, Stevens et al. showed that the 
Bsa TTSS is critical for B. pseudomallei’s ability to invade and replicate in J774.2 
murine macrophages and for vacuolar escape following host cell invasion.19 Similar 
to MxiH and PrgI, deletion of the last five residues of BsaL14 prevented self-
association and yielded soluble proteins that allowed biophysical studies including the 
NMR structural determination of BsaLCΔ5. 
In this chapter, the NMR structure of the needle protein of B. pseudomallei, 
BsaL, lacking its five C-terminal residues (BsaLCΔ5) is described. BsaLCΔ5 is 
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composed of two well-defined helices withing the central portion of the protein’s 
primary sequence, and flanked by residues that appear to adopt a partial α-helical 
conformation. The NMR data rule out the possibility of an internal β-strand and 
provide insight into the possible sites of the monomer-monomer interactions that are 
likely to be needed to form the B. pseudomallei Bsa TTSA needle. The NMR 
structure determination of BsaL was done as collaboration with Lingling Zhang (Dr. 
Picking’s lab). Lingling Zhang initiated the project and prepared the NMR samples, 
acquired the NMR data, and assigned the backbone resonance of BsaLCΔ5. My 
primary contributaion is in the assignment of NOESY datasets, generation of 
restraints, building initial structural models and the NMR structure calculation and 
refinement of BsaLCΔ5. 
 
MATERIALS AND METHODS 
Protein Expression and Purification 
The expression plasmid of BsaLCΔ5 was from Dr. Wendy L. Picking and Dr. 
William D. Picking. Lingling Zhang overexpressed and purified BsaLCΔ5. Details 
about protein expression and purification of BsaLCΔ5 can be found in Lingling 
Zhang’s doctoral dissertation. 
 
NMR Spectroscopy and Structure Calculation 
NMR data were acquired at 25°C on a Bruker Avance 800 MHz NMR 
spectrometer equipped with a cryogenic triple-resonance probe. Resonance 
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assignments were obtained from 2D 1H–15N HSQC21 and 1H–13C-HMQC22 and the 
following 3D datasets: HNCA,23 HNCO,24 CBCA(CO)NH,23 15N-edited NOESY-
HSQC (tmix 120 ms)25 and 13C-edited HMQC-NOESY (tmix 120 ms) ( Table 2-S1).26 
NMR data were processed using NMRPipe27 and analyzed using NMRView.28 Inter-
proton distance restraints were obtained from the NOESY datasets above and were 
classified based on peak volumes into upper bounds of 2.7, 3.5, 4.5 and 5.5 Å and 
lower bound of 1.8 Å. Based on the secondary chemical shifts (Fig. 2-2),29 the 
backbone dihedral angles of residues in helix α1 and α2 were restrained to 
φ =−60(±20)° and ψ=−40(±20)°. Additional negative φ restraints were imposed on 
non-glycine residues based on the chemical shifts.29 Structure calculations and 
refinement were performed as follows. An initial set of 200 structures were generated 
by torsion angle dynamics using CYANA,30 and 100 structures with the lowest target 
functions were further refined by molecular dynamics and simulated annealing in 
vacuo using AMBER7 with the ff99 force field. From this, a set of 50 structures with 
the lowest energies were further refined in AMBER7 with the generalized Born (GB) 
potential. Details of AMBER calculations can be found in Dames et al.31 Twenty 
structures with the lowest AMBER energies were analyzed by PROCHECK32 and 
graphics were made using MOLMOL33 and PyMOL34. 
 
RESULTS 
Preparation of BsaLCΔ5 for Structural Analysis 
 20
 
Figure 2-2. Secondary chemical shifts obtained by subtracting the random coil 13Cα, 
1Hα, 13Cβ, and 13C′ chemical shift values from those observed in the protein indicate 
the presence of two well-defined helices in the middle of BsaLCΔ5.14 
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Recombinant B. pseudomallei BsaL that lacks five C-terminal residues and 
possesses a His6 C-terminal tag was subcloned in the NdeI/XhoI sites of pET-22b 
vector (Novagen) and was expressed and purified by Ni2+-chelation chromatography 
as described.13 CD data indicated that BsaLCΔ5 was rich in α-helical secondary 
structure (approximately 70%) and was similar, in this respect, to MxiHΔ5 and 
PrgIΔ5.13 The 2D 1H–15N heteronuclear single quantum coherence (HSQC) spectrum 
of recombinant BsaLCΔ5 (Fig. 2-3) showed a narrow 1H chemical shift range with 
well-dispersed peaks, consistent with the likelihood that this protein contained a high 
degree of α-helical structure. NMR structure determination was performed on 
BsaLCΔ5 because of the high degree of solubility and apparently well-defined 
structural content of BsaLCΔ5. 
 
NMR Spectroscopy of BsaLCΔ5 
Analysis of 3D HNCA (Fig. 2-S1),23 CBCA(CO)NH (Fig. 2-S2),23 HNCO 
(Fig. 2-S3),24 13C-edited HMQC-NOESY,26 and 15N-edited NOESY-HSQC (Fig. 2-
S4)25 experiments (Table 2-S1) afforded near complete sequence-specific backbone 
and side-chain resonance assignments of BsaLCΔ5. Ser2 and three residues at the C 
terminus, Met77–Asp79, are missing from the 1H–15N HSQC spectrum due to 
exchange broadening and could not be assigned. The His residues in the C-terminal 
His6-tag are disordered, as shown by secondary chemical shifts in the random coil  
 22
 
Figure 2-3. The 2D NMR 1H, 15N correlation spectrum (HSQC) of the recombinant 
15N-labeled BsaLCΔ5 showed well-dispersed peaks and a narrow proton chemical shift 
range of about 1.5 ppm, suggesting a predominantly helical structure. Assignments 
are indicated, and the insert shows the expansion of the central portion of the 
spectrum (boxed).14 
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range, and 15N and 13C NOESY peaks that showed only strong intraresidue nuclear 
Overhauser effect (NOE) peaks. Analysis of the Hα, Cα, Cβ, and C′ secondary 
chemical shifts (Fig. 2-2) suggested the presence of two well-defined helices in 
BsaLCΔ5 (Fig. 2-2).29 This was further confirmed by the NOE patterns,35 such as 
HN(i)-to-HN(i+2), (where i=residue number), Hα(i)-to-Hβ(i+3), and Hα(i)-to-HN(i+4) 
NOEs (Fig. 2-S5), suggesting that these helices adopt a regular α-helix conformation. 
 
The Central Portion of BsaLCΔ5 Forms a Two-Helix Bundle 
Structure calculation and refinement using CYANA and AMBER yielded 
well-converged structures (Fig. 2-4A) with low energies and low distance and 
dihedral angle restraint violations (Table 2-1). A total of 716 NOE-derived distance 
restraints and 67 φ and 33 ψ dihedral angle restraints were used in the structure 
calculation (Table 2-1). PROCHECK analysis of the ensemble of 20 low energy 
structures showed that more than 99% of the residues are within the allowed region of 
the Ramachandran plot (Table 2-1). The central portion of BsaLCΔ5, spanning from 
Lys30 to Asn68, forms the highly structured core domain of BsaLCΔ5, which has two 
well-defined helices joined by an ordered, four-residue turn. More than 80% of the 
assigned NOEs and nearly all of the long-range NOEs are found within this core 
domain, yielding an average of about 15 restraints per residue (Table 2-1). Helix α1 
has five helical turns and spans residues Lys30–Asn46. This is followed by a highly 
ordered linker composed of Pro47-Ser-Asp-Pro50, which immediately connects with 
















Figure 2-4. (A) Stereo view of the 20 lowest energy NMR structures of BsaLCΔ5 
showing residues Asp27–Ser72. Residues Lys30–Asn68 form the well-defined core 
domain of BsaLCΔ5. The rest of the molecule does not adopt a single conformation 
and, therefore, will not superimpose. (B) Ribbon diagram of the lowest energy NMR 
structure of BsaLCΔ5, showing the residues that form the hydrophobic contacts at the 
interface of helix α1 and α2. ((C)–(E)) Surface representations showing the polar 
residues that line the surfaces of the core domain of BsaLCΔ5. The side-chain 
functional groups of residues on the surface are colored as follows: amides blue, 
carboxyls and hydroxyls red, methylenes green, and the methionine sulfur atoms 
orange. The amino and carboxy termini are labeled N and C.14 
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Table 2-1. Number of restraints for BsaLCΔ5 (residues M1-I85) and the core domain 






The Two Helix bundle Is Stabilized by Hydrophobic Interaction 
The BsaLCΔ5 core domain is stabilized by hydrophobic interactions (Fig. 2-
4B), mediated by residues that are also conserved among needle proteins (Fig. 2-1). 
The hydrophobic side of the amphiphatic helix α1 forms direct contact with the 
hydrophobic side of helix α2. The two helices pack at an angle of 24°, and the 
interface is formed by the hydrophobic interactions of Leu32, Leu36, Ala39, and 
Leu43 on helix α1 with Tyr63, Met60, Ile59, Tyr56, Leu53, and Ala52 on helix α2. 
The aromatic rings of Tyr56 and Tyr63 are stabilized by hydrophobic contacts. The 
Tyr56 ring is sandwiched between the hydrophobic side-chains of Leu43 and Met60, 
and forms additional contacts with the methylene groups of Gln40 and Gln67. 
Similarly, the Tyr63 ring is wedged between Leu36 and the methylene groups of 
Arg67 with additional contacts to side-chains of Leu32 and Gln64 (Fig. 2-4B). 
 
The Surface of the Core Domain Is Lined with Polar Residues 
The surfaces of the core domain are dominated by polar groups. One side is 
lined with polar residues: Gln40, Gln37, Asn33 on helix α1 and Gln57, Ser61, Gln64, 
and Asn68 on helix α2. In addition, the hydroxyl groups of Tyr56 and Tyr63 are 
pointed toward the surface and contribute to the overall polarity of this side. Asn68 is 
conserved among needle proteins (Fig. 2-1); however, it does not participate in 
hydrophobic contacts at the helix α1-α2 interface, suggesting that it might be involved 
in functions other than stabilizing the core domain. The other side of BsaLCΔ5 is also 
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lined with polar residues: Lys30, Asp31, Lys34, Gln35, Asp38, Asn42, and Lys45 on 
helix α1 and Thr51, Asn55, Gln57, and the hydroxyl group of Tyr66 on helix α2 (Fig. 
2-4C). The linker between helix α1 and α2 is also polar, comprised of Ser48 and 
Asp49 and close to the nearby Asn46 at the end of helix α1 (Fig. 2-4C). The polar 
nature of the helix-turn-helix core domain of BsaLCΔ5 suggests that this domain is 
solvent-exposed in the needle apparatus. 
 
Significance of Two trans Proline Residues of BsaLCΔ5 
The two proline residues located at the center turn, the PxxP motif, of 
BsaLCΔ5, Pro47 and Pro50, are in trans conformation, as evidenced by strong NOEs 
from the proline Hδ protons to the Hα protons of the preceding residues, Asn46 and 
Asp49, respectively (Fig. 2-S6). The trans conformation of these two Pro residues 
constrains the orientation of helices α1 and α2, so that they must be positioned next to 
each other. That is, they must assume a structure that is very close to the final global 
fold of the core domain of the needle protein. These two Pro residues are highly 
conserved among TTSA needle proteins in diverse bacterial species (Fig. 2-1). The 
constraining action of these two Pro residues suggests a role in the folding of all these 
needle protein homologues and may provide an explanation for the reversible 
unfolding of the protein in vitro.13 
 
Residues Flanking the Core Domain 
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The first seven residues of BsaLCΔ5 are unstructured. These residues have no 
apparent secondary structures from chemical shifts and show only intra-residue NOEs 
(Fig. 2-S5). Based on sequential NOE patterns, the three proline residues in this 
region, Pro4, 5, and 7, are all in trans conformation, with a minor cis conformation 
also observed for Pro4. The regions flanking the well-defined core domain of 
BsaLCΔ5, Ala10 to Gly28 at the N terminus and Ser71 to Ile84 at the C terminus, are 
partially ordered. They exhibit medium-range NOE patterns that are more 
characteristic of α-helical structures. For example, residues from Leu9 to Gly28 and 
Ser71 to Ile84 showed a consistent pattern of Hα(i)-to-Hβ(i+3) NOEs, with weaker 
intensities compared to the corresponding Hα(i)-to-Hβ(i+3) NOEs found in helix α1 
and α2 (Fig. 2-S5). There are also sequential HN(i)-to-HN(i+1) NOEs found from Leu8 
to Gly28, and for some of the residues between Ser71 to Ile84, again with weaker 
intensities compared to those found in helix α1 and α2. It is not possible to ascertain 
the presence (or absence) of weak HN(i)-to-HN(i+1) NOEs between Ser71 and Ile84 
with the available NMR data due to spectral overlap. The NOE patterns suggest the 
regions flanking the core domain are not completely disordered but are more likely to 
be in partial-helical conformations. 
 
No β-hairpin in BsaLCΔ5 
In the absence of high-resolution structural data for the needle proteins of 
TTSA, the Salmonella flagellar filament FliC was used to predict the structure of the 
needle proteins of TTSA.7; 13 This secondary structure prediction suggested the 
 30
presence of a β-hairpin in the needle proteins,7; 13 corresponding to residues Tyr63-
Gln70 of BsaLCΔ5. This is not supported by the NMR data presented here. The 
secondary chemical shifts, NOE patterns, and NMR structure indicate that Tyr63–
Gln70 forms the C-terminal part of helix α2 and cannot be in a β-hairpin 
conformation. Based on the sequence similarity, it is predicted that other needle 
proteins will also fail to have a β-hairpin in this region (Fig. 2-1). 
 
Structural homology with other proteins 
As expected, the two-helix bundle is a common structural feature of many 
proteins, and a search using DALI36 yielded at least 52 proteins that are structurally 
homologous to the core domain of BsaLCΔ5. These proteins contain helix-turn-helix 
structures that can be superimposed with the core domain of BsaLCΔ5 with a root-
mean-square deviation (RMSD) of 2.0 Å or better. Protein bearing similar fold varies 
from membrane proteins, enzymes, chaperones, and transcription factors found in 
eukaryotes, bacteria, and viruses that are involved in cell adhesion, gene regulation, 
signaling, and metabolism. What is noteworthy is the lack of sequence identity among 
these proteins. Of the 52 proteins, 42 had sequence identity below 10% with the 
highest identity being a designed protein (23%). Among naturally occurring proteins, 
the highest sequence identity was from a yeast chaperone protein (18%). There is 
structural homology with another TTSS protein, YscE, of Y. pestis,37 which had a 





The bacterial type III secretion apparatus consists of a basal body that spans 
the inner and outer membranes of Gram-negative bacteria and an external needle 
formed by the polymerization of multiple copies of a single type of protein into a 
tube-like helical assembly (Fig. 1-1).38 These substructures give rise to an apparatus 
that is capable of delivering bacterial proteins into eukaryotic cells for the subversion 
of normal cellular functions. Upon assembly, the needle apparatus has a 25 Å 
diameter channel that is used for translocating bacterial effector proteins into the host 
cell membrane and cytoplasm (Fig. 1-3). For high-resolution structural determination 
of monomeric needle proteins, it was necessary to consider potential problems that 
could arise from the intermolecular protein–protein interaction of recombinant needle 
subunits. Such issues probably reflect the lack of high-resolution structures for any 
TTSS needle protein in the literature. Fortuitously, deletion of the C-terminal five 
residues of the needle proteins MxiH from Shigella,13 PrgI from Salmonella,13 and 
BsaL19 results in the production of monomeric forms of these proteins. Monomers 
produced in this way retain extensive native secondary structures, as determined by 
biophysical characterization,13 thus allowing high-resolution structure determination 
of these needle protein monomers. The central portion of the needle proteins shows 
strong sequence conservation (Fig. 2-1) and all of those purified as monomers appear 
to have very similar secondary structures that are rich in α-helical content.13 It was 
expected that structure determination for any one of the needle proteins would 
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provide a significant contribution to the current understanding of how needle protein 
structure correlates with its biophysical properties, its polymerization into type III 
secretion apparatus needles, and possibly its role in pathogenesis. 
Recombinant BsaLCΔ5 showed ideal characteristics needed for NMR-based 
structure determination. BsaLCΔ5 displayed near-millimolar solubility and well-
dispersed peaks in the 2D 1H–15N HSQC spectrum (Fig. 2-3), making it highly 
suitable for NMR structural characterization. Analysis of secondary chemical shifts 
clearly identified two well-defined helices (Fig. 2-2) and further analysis of the 
NOESY datasets yielded a good number of distance restraints (Table 2-1), which 
allowed for atomic-level structure determination with good structural statistics. 
As a monomer, the central portion of BsaLCΔ5 forms a well-structured, two-
helix bundle. The first seven residues are completely disordered, and the regions 
flanking the well-structured core domain are partially ordered. This is reflected in a 
higher number of distance restraints, averaging about 15 restraints per residue within 
the central region. In contrast, the flanking regions showed medium-range NOEs that 
are characteristics of α-helical structures. The NMR structure of BsaLCΔ5 (Fig. 2-4A) 
supports the CD data showing that this needle protein is predominantly α-helical and 
it is likely that PrgI (Salmonella) and MxiH (Shigella) have similar structures as 
well.13 The data presented here do not, however, support the previous suggestion that 
there may be a β-hairpin within the C-terminal half of these needle proteins.7; 13 The 
core domain is stabilized by hydrophobic interaction and the surface is lined with 
polar residues, suggesting that this part of the needle protein may be solvent exposed 
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in the needle apparatus. The atomic structure of BsaLCΔ5 could also account for 
associated phenotypes of some of the point mutants that have been made on the 
homologous needle protein of S. flexneri, MxiH, where a larger body of biological, 
biochemical and genetic data are available.7 For example, the MxiH mutant Y57A 
results in a TTSS that is incapable of inducible secretion and a TTSA that forms 
unusually short needles.7 This mutation most likely disrupted the hydrophobic 
interactions that stabilize the core domain, since the equivalent residue in BsaL, Y63, 
lies at the heart of the BsaL monomer helix-helix interface. 
The two-helix bundle is a common structural motif in biology and numerous 
proteins share structural homology with the core domain of BsaLCΔ5, despite an 
absence of overt primary sequence similarity. One protein from Yersinia, YscE, 
shares 14% sequence identity and has a backbone RMSD value of 1.9 Å with the core 
domain of BsaL. YscE is classified in the Protein Data Bank as a type III secretion 
chaperone, and was reported by Phan and co-workers37 to form dimers in solution. 
The homolog of YscE in Pseudomonas, PscE, together with another protein, PscG, 
forms a stable ternary complex with the needle protein, PscF, which then prevents the 
premature polymerization of the needle protein in the bacterial cytoplasm.39 A 
functional homolog of YscE/PscE in the Burkholderia Bsa TTSS has not been 
identified. 
Based on the atomic structure of BsaLCΔ5, additional experiments are needed 
to answer the question of how two BsaL monomers might interact to form an external 
TTSA needle. A working hypothesis is that the intermolecular contacts between the 
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needle molecules required for self-assembly reside within the N-terminal residues 10–
25 and involves the last five residues at the C terminus of BsaL, and upon complex 
formation, these residues form helical structures that pack against each other. This is 
consistent with the model of how needle subunit proteins might polymerize based 
upon similarities to the flagellar structure.3; 7; 38 The flagellar structure is assembled 
by intermolecular helix-helix packing between monomers.40 The results presented 
herein indicate that the residues flanking the core domain are not completely 
disordered, but are best characterized as having partial helical character, hence 
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Table 2-S1. Details of NMR experiments used for BsaLCΔ5. 
NMR Experiment Bruker Pulse 
Sequence 
Experimental Details Time* 
2D HSQC hsqcfpf3gpphwg 8 NS* 2048×128 (N) pts 20 min 
2D HMQC blhmqcnoesy2d 8 NS 2048×256(C) pts 1h 30min
3D HNCA hncagpwg3d 16 NS 2048×48(N)×70(C)   
pts 
18h 
3D CBCA(CO)NH cbcaconhgpwg3d 16 NS 2048×48(N)×100 (C) 
pts 
1d 





16 NS 2048×44(N)×256 (H) 
pts 
2d 17h 





rdhsqcnoef3gpsi 24 NS 2048×360 (N) pts 19h 
 
NS*: number of scans 








Figure 2-S1. Portion of the 3D HNCA strips of 13C, 15N-labeled BsaLCΔ5, shown as 
13C, 1H strips for Ile59-Tyr63 (the 15N ppm is on the Z-axis). Each strip shows the Cα 
of the preceeding and current residue and the amide (1H and 15N) resonances of the 
current residue, indicating a sequence specific connectivity between these strips. In 
theory, the 3D HNCA dataset contains all the information needed in assigning all the 
backbone resonances of a protein. However, peak overlaps make assignments 
ambiguous; and a combination with the CBCA(CO)NH and 15N-HSQC-NOESY 










Figure 2-S2. Portion of the 3D CBCA(CO)NH strips of 13C, 15N-labeled BsaLCΔ5, 
shown as 13C, 1H strips for Ile59-Tyr63 (the 15N ppm is on the Z-axis). Each strip 
shows the Cα and the Cβ of the preceeding residue and the amide (1H and 15N) 
resonances of the current residue. 3D CBCA(CO)NH was collected to assist in the 








Figure 2-S3. Portion of the 3D HNCO strips of 13C, 15N-labeled BsaLCΔ5, shown as 
13C, 1H strips for Ile59-Tyr63 (the 15N ppm is on the Z-axis). Each strip shows the 
13C’ (carbonyl) peak of the preceeding residue and the amide (1H and 15N) resonances 
of the current residue. HNCO dataset was collected to determine the carbonyl atom 
secondary chemical shifts of BsaLCΔ5, which is a good indicator of the presence of α-
helix or β-strand in proteins. 
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Figure 2-S4. Portion of the 3D 15N-edited HSQC-NOESY strips of 15N-labeled 
BsaLCΔ5, shown as 1H, HN strips for Ile59-Tyr63 (the 15N ppm is on the Z-axis). Each 
strip shows all the backbone HN NOE peaks including its own HN and the HNs of the 
preceding and following residues, indicating connectivity between these residues 





Figure 2-S5. The long-range NOE restraints (dark bars) are clustered in the in the α-
helical regions of BsaLCΔ5 (V29-Q70). The flanking regions (A10-G28 and S71-I84) 
have medium range (gray bars) and sequential (white bars) NOEs. (B) The well 
defined two-helix bundle in the middle of BsaL (helix α1 and α2) have the 
characteristic α-helical NOE patterns. Both the N-terminal region (A10-G28, shaded) 




Figure 2-S6. Strips of the two Hδ protons of residue Pro50 in 3D 13C-edited HMQC-
NOESY of 13C, 15N-labeled BsaLCΔ5, showing the proline trans configuration. NOE 
peak intensity of previous residue Asp49 Hα was stronger than the Pro50 Hα. The Z-
axis is at Pro50 Cδ chemical shift at 51.339 ppm. 
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Chapter 3: Solution Structure Determination of PrgI 
 
INTRODUCTION 
Salmonella typhimurium is a major intestinal pathogen associated with food 
poisoning and is estimated to cause 2 to 4 million cases of salmonellosis in the U.S. 
annually.1 Salmonellosis contributes significantly to hospitalization and mortality 
among susceptible individuals such as the elderly, children, and people with 
compromised immune systems caused by AIDS and chemotherapy.1  
Salmonella encodes two TTSSs on two Salmonella pathogenicity islands 
(SPI1 and SPI2).2; 3; 4 SPI1 is necessary for invasion into the nonphagocytic cells of 
the intestinal epithelium.5 Salmonella promotes its own uptake into nonphagocytic 
cells by subverting the normal function of several signaling pathways that control the 
formation of transient actin-rich membrane ruffles that engulf the infecting bacterium 
(Fig 1-2).6 Inside the host cells, becteria will be allowed to reside and replicate in a 
privileged site, minimizing exposure to the immune system of the host.6 SPI2 genes 
are expressed only after inside the host cells and are required for the later stage 
survival with macrophages and subsequent systemic infection.7; 8; 9; 10   
S. typhimurium uses a type III secretion apparatus (TTSA) to inject host 
altering effector proteins into eukaryotic cells. On the surface of the S. typhimurium, 
PrgI monomers assemble into a needle-like structure, and electron microscopy 
revealed a tube-like structure with dimensions 130 Å × 800 Å (diameter versus 
length).11 PrgI is homologous to BsaL (Burkholderia) and MxiH (Shigella). The first 
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reported atomic resolution structure of a needle monomer is the NMR structure of 
BsaL.12 Other groups subsequently solved the crystal structure of the S. flexneri MxiH 
needle protein, which showed a disordered N-terminal region and a longer C-terminal 
helix (Fig. 3-1).13 Nevertheless, the structured region of BsaL can be superimposed to 
MxiH with a 3.2 Å Cα root-mean-square deviation (RMSD) (Fig. 3-1). Later, the 
crystal structures of two other needle proteins, PscF14 from Pseudomonas aeruginosa 
and YscF15 from Yersinia pestis, were solved, but when bound to their two respective 
chaperones (Fig. 3-2). The structures of PscF14 and YscF15 are different from the 
structures of BsaL12, MxiH13, and PrgI16, which is probably due to the methods used 
to prevent the self-polymerization of PscF and YscF. Deleting a small number of C-
terminal residues does not lead to readily purifiable PscF and YscF monomers. The 
C-terminal 31 residues of PscF in the ternary complex (with its chaperones PscG and 
PscE) form a short ordered region and a short helix similar to the C-terminal helix of 
MxiH, leaving the rest of the protein disordered (Fig. 3-2). Similarly, residues 50–87 
of YscF (with its chaperones YscG and YscE) form an α-helical hairpin with a five-
residue linker from Ile64 to Asn68 and the first 49 residues displayed no electron 
density (Fig. 3-2). In both ternary complexes, more than half of PscF and YscF N-
terminal residues, including the region equivalent to the PxxP motif, are missing or 
disordered in the crystals. The structures of PscF and YscF show how bacteria 
prevent the premature self-polymerization of needle monomers while inside the 
bacterial cytoplasm; however, no chaperones have been reported for BsaL, MxiH, or 
PrgI. Questions about whether these dramatic structural differences between PscF and  
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Figure 3-1. (A) Two different MxiHCΔ5 forms (form A and form B) were observed in 
the crystal packing (PDB 2CA5). Two forms differ on second helix α2 and the 
boundary of the two helices.  (B) The core domain two helices of MxiHCΔ5 form A 
superimposed with BsaLCΔ5 yields a 3.2 Å RMSD over Cα. 
 
 
Figure 3-2. Needle proteins PscF (A) and YscF (B) together with their respective 
chaperones form ternary complexes. Only the structured part of the needle proteins 
PscF (M54-I85) and YscF (L50-P87) are shown in green, with the chaperones 
PscG/PscE and YscG/YscE colored in light grey and black, respectively.17 
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YscF with BsaL, MxiH and PrgI will lead to different needle packing remain 
unknown.  
Despite sequence conservation, needle proteins have widely different thermal 
stabilities, with melting temperatures of 37°C for PrgI, 42°C for MxiH, and 54°C for 
BsaL18. In addition, PrgI does not complement a S. flexneri mxiH null mutant, 
implying that the needle proteins of S. typhimurium and S. flexneri are not 
interchangeable despite 63% sequence identity between PrgI and MxiH. These 
observations suggest there might be distinct structural features of PrgI, which makes 
the atomic structure determination of PrgI necessary for understanding its biological 
function.  
  
MATERIALS AND METHODS 
Expression and Purification of PrgICΔ5 
The plasmid expressing recombinant S. typhimuriumi PrgI lacking five C-
terminal residues and possessing a His6 C-terminal tag, which was obtained from Dr. 
William D. Picking (University of Kansas), was subcloned in the NdeI/XhoI sites of 
pET-22b vector (Novagen) as described.18 PrgICΔ5 is similar to the BsaLCΔ5 and 
MxiHCΔ5 constructs used in previous structure determinations where the last five 
residues were deleted and replaced with a C-terminal His6-tag.12; 13 Uniformly 
13C,15N- and 15N-labeled PrgICΔ5 were obtained by growing Escherichia coli 
BL21(DE3) with the plasmid pET-22b-prgICΔ5 in 1 liter of minimal media 
supplemented with 2 g/L of [13C]glucose and/or 1 g/L of [15N]ammonium chloride. 
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Cells were grown at 37°C, induced with 1 mM IPTG (isopropyl-β-D-
thiogalactopyranoside) at A600 0.8, and expressed overnight at 15°C to a final A600 of 
2.4. Cells were centrifuged, resuspended in 40 ml of buffer A (20 mM Tris (pH 7.9), 
500 mM NaCl) with 5 mM imidazole, and sonicated. Cellular debris was removed by 
centrifugation and the supernatant was loaded on a 5 ml Ni2+-affinity column (Sigma) 
that was previously treated with 35 ml of water, 35 ml of 50 mM NiSO4, and 35 ml of 
buffer A with 5 mM imidazole. The Ni2+-column was washed with 35 ml of buffer A 
with 60 mM imidazole and eluted with 15 ml of buffer A with 1 M imidazole in 1 ml 
fractions. Fractions were analyzed by SDS-PAGE gel and high concentration 
fractions were pooled. Protein samples were then dialyzed in NMR buffer (10 mM 
sodium phosphate pH 6.0, 10 mM NaCl) and protein concentration was estimated by 
UV absorbance at 280 nm. 
 
NMR Spectroscopy of PrgICΔ5 
NMR data were acquired at 25°C using a 0.8 mM protein sample on a Bruker 
Avance 800 MHz spectrometer, processed with NMRPipe,19 and analyzed using 
NMRView.20 Resonance assignments were obtained from 2D 1H-15N HSQC21 and 
1H-13C HMQC22 and the following 3D datasets: HNCA23, HNCO24, CBCA(CO)NH23, 
HNCACB25 and HBHACONH26 (Table 3-S1). Water suppression was achieved using 
flip-back pulses and pulsed field gradients. The α-helices were identified from the Cα, 
Cβ, and Hα secondary chemical shifts.27 The 1H, 13C, 15N chemical shifts were 
referenced indirectly using 2,2-dimethyl-2-silapentane-5-sulfonate (DSS). Inter-
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proton distance restraints were obtained from 3D 15N-edited NOESY-HSQC 
(tmix = 120 ms) and 13C-edited HMQC-NOESY (tmix = 120 ms) (Table 3-S1). 
 
Salmonella Invasion Assay 
The functional Salmonella invasion assay was done using the gentamycin 
protection invasion assay with cultured human epithelial cells. We followed a 
published protocol to examine the ability of S. typhimurium to invade the cultured 
human epithelial cell line Henle 407.28 Henle 407 cells were obtained from the 
American Type Culture Collection (ATCC # CCL-6). S. typhimurium wild-type 
(SL1344) and prgI null mutant (JK17)29 strains were obtained from Dr Bradley Jones 
(University of Iowa). Briefly, Henle 407 cells were grown in Eagle's modified 
minimum essential medium with 10% (v/v) newborn calf serum in 5% (v/v) CO2. All 
prgI mutant plasmids (ampicillin and trimethoprim resistence) were transformed into 
S. typhimurium JK17 (ampicillin and kanamycin resistence) 16; 29 by electroporation. 
The bacteria were cultured fresh each time and the bacterial plates were streaked 2 
days before the experiment. The following day, bacteria were grown in 10 ml LB 
media containing the appropriate antibiotics (kanamycin, ampicillin, and 
trimethoprim) in standing cultures (without shaking) at 37°C. When bacterial density 
reached A600~0.5, 10~20 μl bacterial suspension was incubated with Henle 407 cells 
for 60 min to allow invasion before removal by aspiration. The Henle 407 cells were 
washed with DMEM media containing 50 μg/ml of gentamycin 3 times and further 
incubated in the gentamycin containing DMEM media for 90 min. The Henle 407 
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cells were then washed with DMEM (Dulbecco’s Modified Eagle Medium) media 
and lyzed with 0.9% (w/v) deoxycholate to free the entrapped bacteria. The number 
of bacterial colonies, which correlates with invasiveness, were estimated by serial 
dilution and plating. All invasion assays for prgI point mutants together with S. 
typhimurium wide-type (SL1344) were done in triplicates. 
 
RESULTS 
NMR Structure Determination of PrgICΔ5 
The last five residues of PrgI were deleted to obtain monomeric PrgICΔ5, 
similar to the approach used in the structure determinations of BsaLCΔ5 and MxiHCΔ5. 
Analysis of NMR datasets (Fig. 3-S1-S5) yielded near complete backbone and side 
chain assignments for PrgICΔ5. We assigned 69 (out of 79) backbone amides (Fig. 3-
3); however, the amides of Ala2, Thr3, Ala35, Ala36, Leu43 and Leu44 are in rapid 
exchange with the solvent and could not be assigned. The Cα, Cβ, and Hα secondary 
chemical shifts indicated the presence of three helices: Val20–Ala35, Pro41–Ser62, 
and Asp70–Glu77 (Fig. 3-4). Assignment of 3D nuclear Overhauser effect 
spectroscopy (NOESY) datasets yielded 1270 interproton distance restraints, or an 
average of 15 NOEs per residue (Table 3-1). Most of the nuclear Overhauser effects 
(NOEs) are in the helical regions and all the long-range NOEs are from the conserved 
hydrophobic residues in the central region of PrgI (Fig. 3-S6). Structure calculations 
using NMR-derived restraints (Table 3-1) and CYANA30 followed by refinement in 
AMBER31 yielded well converged NMR structures of PrgICΔ5 (Fig. 3-5). The NMR  
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Figure 3-3. Assigned 1H-15N HSQC spectrum of PrgICΔ5. The inset shows an 
expansion of the crowded region of the spectrum. The side-chain peak of Trp5 (not 




Figure 3-4. Secondary chemical shifts obtained by subtracting the random coil 13Cα, 
1Hα and 13Cβ chemical shift values from those observed in the protein indicate the 








Figure 3-5. Stereo view of the superposition of 20 lowest energy structures of 
PrgICΔ5, showing only the backbone N, Cα, and C′ atoms. Only the region Val20–
Val65 can be superimposed into an ensemble of NMR structures, forming the core 
domain of PrgICΔ5; however, the regions flanking this core domain, from Trp5–Gly19 











structures yielded good structural statistics (Table 3-1), and over 85% of the residues 
are in the most favorable region of the Ramachandran plot. 
 
Central Region Forms a Two-helix Bundle 
Only the central region (Val20–Val65) of PrgICΔ5 converged into a single 
family of NMR structures and formed an ordered two-helix bundle (Fig. 3-5). The 
regions flanking this two-helix bundle (Pro4–Gly19 and Lys66–Ile75) lacked long-
range NOEs and did not converge; however, each of the 20 NMR structures showed a 
helical conformation for Pro4–Gly19 and Lys66–Ile75 that is consistent with the 
observed NOE patterns (Fig. 3-S6). The well-defined two-helix bundle is composed 
of the PxxP loop (Pro38–Pro41) and parts of helix α1 (Val20–Ala36) and α2 (Ala42–
Val65). The helix α1–α2 interface (Fig. 3-6) is stabilized by conserved hydrophobic 
contacts of residues on helix α1 (Val20, Leu23, Val27, Ala30, Leu34) and helix α2 
(Leu43, Leu44, Tyr47, Tyr54, Leu56). Val20 contacts the methylene groups of Gln24 
and Arg58 and the phenyl ring of Tyr54 (Fig. 3-6A). L23 packs against the methylene 
groups of Gln26, Lys50, Glu53, Tyr54 and Tyr57 (Fig. 3-6); and Val27 is in a 
hydrophobic pocket formed by Gln24, Leu31, Tyr47, Leu51, and Tyr54 (Fig. 3-6B). 
The methyl group of the conserved Ala30 residue is in the helix α1–α2 interface but 
does not pack directly with any helix α2 residue (Fig. 3-6A), suggesting that a small 
amino acid is required in this position. Finally, Leu34 packs with helix residues 











Figure 3-6. PrgICΔ5 forms a two-helix bundle stabilized by hydrophobic contacts at 
the helix α1–α2 interface. The side-chains of the hydrophobic and polar residues are 
shown; A is oriented by a 180 rotation from B. Atoms are colored as: red, oxygen; 
blue, nitrogen; gray, carbon.16 
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The Surface of the Two-helix Bundle Is Polar 
The surface of the two-helix bundle of PrgI is polar due to residues on helix α1 
(Asn22, Asp21, Gln24, Thr25, Gln26, Glu29, Lys33, and Asp32), helix α2 (Gln48, 
Ser49, Lys50, Ser52, Glu53, Asn55, Arg58, Asn59, and Ser62), and the PxxP region 
(Lys27, Ser39, and Asp40) (Fig. 3-6). Most of these polar residues are pointed away 
from the two-helix bundle and therefore are not needed to stabilize the hydrophobic 
core of the two-helix bundle, however, several polar residues are identical (Gln48, 
Asn59, and Ser62) or conserved (Gln24, Glu53, Asn55, and Arg58) among needle 
proteins, suggesting that they are important for function other than stabilizing the core 
domain. Other residues that contribute to surface polarity are the conserved Tyr47 
and Tyr54. While the Tyr47 and Tyr54 phenyl rings are required to stabilize the 
hydrophobic core, their hydroxyl groups are pointed towards the polar surface (Fig. 3-
6B). Another polar moiety is the Gln26–Lys50 hydrogen bond in the middle of the 
two helix bundle of PrgI (Fig. 3-6A), which is in a position equivalent to the MxiH 
Glu29-Lys53 salt bridge.13 BsaL, however, does not have any electrostatic 
interactions equivalent to that of PrgI Gln26-Lys50 or MxiH Glu29-Lys53.13 
Residues Gln24, Tyr54, Asn55, and Arg58 are clustered together on the surface of 
PrgI and form a polar patch at the base of the two-helix bundle (Fig. 3-6B).  
 
Electrostatic Surfaces Are Different 
The needle monomers are acidic proteins with theoretical pI's of 4.76 (PrgI 




Figure 3-7. The electrostatic surface of (A) PrgI, (B) BsaL, and (C) MxiH are shown 
together with the ribbon structures showing the relative orientation of the two-helix 
bundle. The structures of PrgI, BsaL, and MxiH are oriented is similar manner from 
top to bottom to allow comparison of the surfaces. The structures on the left are 
rotated by 180° along the y-axis from the right.16 
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negatively charged surfaces (Fig. 3-7). The locations of the negatively charged 
surfaces, however, are radically different among PrgI, BsaL, and MxiH. In PrgI, the 
largest negatively charged surface is located on the “side” of the two–helix bundle 
and spans almost the entire length of helix α1, from the PxxP motif to the base of the 
two helix bundle (Fig. 3-7A). This is in sharp contrast to BsaL and MxiH where the 
negatively charged surfaces are on the “face” of the two-helix bundle (Fig. 3-7B and 
c). In BsaL, the negatively charged surface is more broadly distributed on the helix 
α1–α2 interface (Fig. 3-7B). Likewise in MxiH, a negatively charged surface potential 
is on the “face” of the two-helix bundle (Fig. 3-7C). In PrgI, residues mostly on helix 
α1 (Ser6, Asp10, Ser13, Thr18, Asn19, Asp21, Thr25, Glu29, and Asp32) contribute 
to the largest negatively charged surface, whereas, in BsaL and MxiH, residues on 
helix α1 and α2 contribute to the negatively charged face. The tail of helix α2 in PrgI 
and MxiH (Fig. 3-7A and 7C), which contains conserved aspartic acids (PrgI Asp70 
and Asp72), also has a significant negatively charged surface. 
Despite being highly acidic proteins, PrgI, BsaL, and MxiH contain 
contiguous regions of basic (or positive) electrostatic potentials (Fig. 3-7). These 
positively charged regions are located similarly among the needle proteins, residing 
near the base of the two-helix bundle and distal to the PxxP motifs (Fig. 3-7). In PrgI 
and BsaL, the positively charged regions at the base of the two-helix bundle are due 
to residues on both helix α1 and α2 (Fig. 3-7A and 7B). In MxiH, however, the 
positively charged surface is solely due to residues on helix α2, starting from the base 
of the two-helix bundle and extending towards the C-terminal end of helix α2 (Fig. 3-
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7C). In PrgI, the positively charged surface is located ~90° away from the negative 
side (Fig. 3-7A), whereas in BsaL and MxiH, the positively charged surfaces are 180° 
away, or on the flip side of the negatively charged surfaces (Fig. 3-7B and 7C). 
 
Mutagenesis and Salmonella Invasion Assay 
We used mutagenesis and assayed the ability of Salmonella to invade a 
cultured human epithelial cell line to assess the role of specific PrgI residues with 
respect to invasiveness (Fig. 3-S7). Wild-type bacteria form functional needles and 
can invade and give rise to hundreds of colonies, whereas a prgI-null mutant strain is 
non-invasive because it lacks a functional PrgI protein (Fig. 3-8). A plasmid that 
introduces wild-type prgI restores the invasiveness of the prgI null mutant. We 
mutagenized Gln26 and Lys50 to probe the importance of the Gln26–Lys50 hydrogen 
bond found in the middle of the two-helix bundle. We hypothesize this interaction 
contributes, albeit weakly, to stabilize the two-helix bundle, and therefore plays a role 
in needle assembly and virulence. Indeed, K50D, which is expected to disrupt the 
Gln26–Lys50 hydrogen bond, was shown S. typhimurium noninvasive (Fig. 3-8). The 
CD data confirmed that K50D was shown unstructured by CD spectroscopy (Fig. 3-8 
and 3-9), suggesting the electrostatic repulsion (from a basic residue K to an acidic 
residue D) prevented the proper folding of PrgI into the two-helix bundle structure. 
K50L cannot participate in polar interactions yet it has wild-type level of 
invasiveness, suggesting it is capable of forming functional needles, and that the 




Figure 3-8. Salmonella invasion assay. The number of bacterial colonies (y-axis) 
correlates with the ability of S. typhimurium to invade a cultured human epithelial cell 
line (Henle 407). Wild-type (WT) bacterium is invasive, whereas a S. typhimurium 
with a prgI null mutation (prgI-) is non-invasive. A plasmid that overexpressed a 
functional PrgI (prgI+) restored the invasiveness of the prgI null mutant strain. Point 
mutations were introduced in the Gln24, Gln26, Tyr47, Lys50, Tyr54 and Arg58 
residues using the PrgI plasmid. The assays were done in triplicate. 
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Figure 3-9. (A) CD spectra of PrgICΔ5 wild type (WT) and point mutants (Q26A, 
Y54F, Y54L, R58L and K50D) showing the characteristic α-helical dips at 208 nm 
and 222 nm except for the K50D mutant. K50D shows a typical CD spectrum of a 
random coil protein, indicating K50D is unstructured. (B) CD thermal denaturation 
curves, monitored at 222 nm, of the wild type and PrgI point mutants. Except for 
K50D, all proteins show similar melting temperatures around 37°C.  
 63
Q26A, which is also expected to disrupt the hydrogen bond and was shown S. 
typhimurium noninvasive, however, was still able to form foled structure similar to 
wild-type PrgI indicating Q26 might be involved in the protein-protein interaction 
(Fig. 3-8 and 3-9). Q26E has wild-type invasiveness because glutamate can form a 
salt bridge with Lys50. Y54L, not Y54F, showed partially defect in S. typhimurium 
invasiveness, suggesting the aromatic ring might contribute to the protein-protein 
interaction. Finally, changing the electrostatic surface with the R58L mutation 
resulted to a non-invasive phenotype (Fig. 3-8), suggesting a function similar to 
residue Q26 and Y54. 
 
DISCUSSION 
TTSA needle proteins self-associate, but a C-terminal deletion was exploited 
to obtain monomeric PrgICΔ5.18 This is similar to the approach used in structure 
determinations for BsaLCΔ5 12 and MxiHCΔ5 13. PrgI has 52% and 63% sequence 
identity with BsaL and MxiH, respectively, and the central region is more conserved 
compared to the N terminus (Fig. 2-1). PrgICΔ5 (Fig. 3-3) and BsaLCΔ5 12gave 
excellent NMR spectra compared to MxiHCΔ5, allowing NMR structure 
determination. The central region of PrgICΔ5 (Fig. 3-5), BsaLCΔ5,12 and MxiHCΔ5 13 
form a core domain composed of two helices that are linked by a PxxP motif. Helix 
α2 is longer than helix α1, which is probably due to glycine and proline residues at the 
N termini, which act as helix breakers. The first 3, 8, and 19 residues of PrgI, Bsal, 
and MixH, respectively, are disordered. In PrgI and BsaL, the N and C-terminal 
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regions flanking the two-helix bundle have residual α-helical conformation and are 
more flexible. The first 19 residues are disordered in the MxiHCΔ5 crystal, however, a 
portion of this region might be in partial α-helical conformation when viewed by 
NMR as in BsaL and PrgI. The regions flanking the two-helix bundle do not fold 
back into the core structure and give the needle proteins an elongated shape instead of 
a globular structure. 
The conserved hydrophobic contacts at the helix α1–α2 interface (Fig. 3-6) 
stabilize the two-helix bundle and are important in needle assembly and pathogenesis. 
More information is known about the effects of mutations on MxiH compared to PrgI 
and BsaL because Kenjale and co-workers32 have characterized the phenotypes of 
over 35 MxiH point mutants (to alanine) with respect to needle assembly, secretion of 
effector proteins, and the ability of S. flexneri to invade cultured epithelial cells. In S. 
flexneri, MxiH L54A or Y57A mutation is defective in needle polymerization and 
secretion of effector proteins and thus is non-invasive.32 The MxiH L54A or Y57A 
(equivalent to PrgI Leu51 and Tyr54) mutation is expected to decrease the 
hydrophobic contacts at the helix α1–α2 interface and destabilize the two-helix bundle. 
The proper folding of the two-helix bundle is thus essential in needle assembly. 
The polar surface of the two-helix bundle is another common feature among 
needle proteins (Fig. 3-6). Conserved tyrosine residues contribute to surface polarity, 
however, the structures of PrgI, BsaL, and MxiH do not show a particular need for 
tyrosine residues in position Tyr47 and Tyr54; and phenylalanine would have 
maintained similar hydrophobic contacts and the overall fold of the two-helix bundle. 
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Yet, Tyr47 and Tyr54 are identical among PrgI, BsaL, and MxiH, suggesting the 
tyrosyl hydroxyl group is important for function. We hypothesize that the conserved 
tyrosine residues are important in protein–protein interactions with other needle 
monomers or with the tip complex.33 Indeed, a MxiH Y50F point mutation, which is 
equivalent to PrgI Tyr47, disrupted the in vivo interaction between the MxiH needle 
and the tip complex and decreased the invasiveness of S. flexneri by 78%.34 Another 
mutation affecting a polar residue, MxiH Q51A (equivalent to PrgI Gln48) showed 
normal needle assembly but decreased invasiveness.32 Structurally, MxiH Gln51 is 
pointed away from the two–helix bundle and does not appear to contribute in 
stabilizing the core structure of the needle protein. However, MxiH Q51 is identical 
among the needle proteins (Fig. 2-1), suggesting that the decreased invasiveness of S. 
flexneri is probably due to defective protein–protein interaction. The polar surface of 
the needle protein is therefore important in pathogenesis. 
Previous results showed that the last five residues are important in needle 
monomer–monomer interaction.18; 32 Other than the last five residues, our data 
suggest that electrostatic interaction is also an important component of needle 
assembly. This is based on the presence of distinct areas of positively and negatively 
charged surface potentials on PrgI, MxiH, and BsaL (Fig. 3-7). Furthermore, this 
work shows that the most significant difference among these needle proteins is in the 
arrangement of their electrostatic surfaces (Fig. 3-7), suggesting that despite primary 
sequence conservation, protein–protein interaction may be different among these 
needle proteins. This could account for the observation that despite 63% sequence 
 66
identity between PrgI and MxiH, PrgI does not complement a S. flexneri mxiH null 
mutant (W.D. Picking, unpublished data). The needle proteins of S. typhimurium and 
S. flexneri are therefore not interchangeable. This also suggests that factors affecting 
electrostatic interactions, such as ionic strength, metal cations, and pH will affect 
needle assembly. The effect of salt concentration and cations on needle assembly 
have not been explored in detail; however, Marlovits et al.35 showed in vitro that 
increasing the pH from pH 8 to pH 10.5 dissociated the needle, but not the basal 
structure of the S. typhimurium needle apparatus. We identified that a conserved 
tyrosine residue (equivalent to PrgI Tyr54) is involved in needle monomer–monomer 
contact by NMR chemical shift mapping of BsaL dimers (Fig. 3-S8 and S9). A 
possible scenario is that high pH changes the protonation of this Tyr54 hydroxyl 
group, which then interferes with needle monomer–monomer contact that leads to the 
dissociation of the needle. 
The Salmonella invasion assay relies on the proper assembly of functional 
needles, therefore, it provides an indirect readout of the PrgI–PrgI interaction 
involved in needle assembly. We mutagenized the polar residues (Gln26, Lys50, 
Arg58) that contribute to the electrostatic surface of PrgI and used the Salmonella 
invasion assay to test their roles in needle assembly (Fig. 3-8). Mutagenesis of Gln26 
and Lys50 suggest that the Gln26-Lys50 hydrogen bond is not critical for 
invasiveness, but the polarity of this region, either through Gln26 or Lys50, and the 
aliphatic moieties of Gln26 and Lys50 are required in needle assembly. Mutagenesis 
also suggests that the hydrophobic packing interaction of the aliphatic groups of 
 67
Gln26 and Lys50 are more important in the structure of the two-helix bundle than the 
hydrogen bonding interaction. Thus, Q26A and K50D, which have decreased 
aliphatic moieties, are non-invasive, whereas Q26E and K50L, which have aliphatic 
parts comparable to wild type, are invasive. The aliphatic part of Arg58, which is 
identical in PrgI, BsaL, and MxiH, participates in intramolecular hydrophobic 
contacts; however, its guanidine group is not involved in any polar interactions but 
contributes prominently to the positively charged surface of the two-helix bundle 
(Fig. 3-7). R58L mutation is non-invasive, suggesting that altering this surface 
polarity is deleterious in needle assembly. 
Using X-ray fiber diffraction and electron microscopy, others showed that the 
S. flexneri needle is a helical structure formed by self-assembled needle monomers 
(Fig. 1-3).36; 37 Combining the reported needle helical parameters and the crystal 
structure of the MxiHCΔ5 monomer, an atomic model of the S. flexneri needle was 
described at 16 Å resolution.13 In their model, Deane et al. assumed that the N-
terminal 19 residues, which were disordered in the MxiHCΔ5 crystal structure, formed 
a well-defined alpha helix that lines the inner channel (Fig. 3-10). They made this 
assumption because secondary structure predictions indicate the N-termini of needle 
proteins were α-helical.32; 38 The major axis of the MxiH monomers was in line with 
the major axis of the needle. The orientation of this model is in agreement with the 
functionally- and structurally-related bacterial flagellar filament assembly.13; 39; 40 The 
PxxP motif, which forms part of the head domain of MxiH, is pointed outwards on 










Figure 3-10. The crystal structure of MxiH monomer and electron microscopy of 
Shigella needles led to the first atomic model of a TTSA needle (PDB ID 2v6l). 
Shown are the (A) side view and (B) end-on view of the needle model.17 
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α-helix that lines the inner surface of the channel. The C-terminus of MxiH is buried 
within the needle wall and is in direct contact with three other MxiH monomers, thus 
showing how deletion of five C-terminal residues prevented the self-polymerization 
of MxiH.32 
To examine the electrostatic contacts between needle monomers, 
Thenmalarchelvi Rathinavelan and Wonpil Im modeled the S. flexneri needle (Fig. 3-
11A–D) using the MxiHCΔ5 crystal structure and the parameters reported in the 
Shigella needle model.36; 37 The model was built with 28 subunits of the MxiHCΔ5 
crystal structure using the CHARMM biomolecular simulation proGram.41 The first 
19 N-terminal residues and the last five C-terminal residues were also modeled to 
form regular α-helices. The N-terminal helix was also modeled to be inside the needle 
channel and parallel to the axis of the channel (the Z-axis). Each subunit was 
translated by 4.31 Å along the Z-axis and rotated by 64.3° around a 25 Å diameter of 
the needle channel. The model was energy minimized with a generalized Born 
implicit solvent model42 in CHARMM to allow the side-chains to adopt low-energy 
conformations and resolve the steric clash between the residues at the binding 
interfaces. To model the S. typhimurium needle, the NMR structure of PrgI was 
superimposed on the backbone atoms (N, Cα, C′) of the MxiH needle and energy 
minimized. 
Within the needle model, the two subunits with the largest surface contact 
were isolated and the electrostatic potentials of this dimer were calculated by solving 




Figure 3-11. (A) Model of the S. flexneri needle created using the crystal structure of 
MxiHCΔ5 (PDB code 2CA5) and published needle packing parameters, and visualized 
with the top towards the host and below towards the bacterium, and along the 25 Å 
needle channel looking down towards the bacterium. (B) Two MxiH molecules 
within the needle with extensive intermolecular contacts are chosen for electrostatic 
analysis. (C) The two monomers, MxiH1 and MxiH2, are separated from the MxiH 
dimer and rotated by 90° towards the viewer to reveal the electrostatic potentials of 
the residues involved in the needle packing interaction. The N-terminal 19 residues of 
MxiH were removed because they were disordered in the MxiH crystal structure. (D) 
Electrostatic analysis of two PrgI molecules (PrgI1 and PrgI2) in the model of the S. 
typhimurium needle, which was created by superimposing the NMR structure of PrgI 
into S. flexneri needle. The N-terminal 19 residues of PrgI were removed in the 
calculation of electrostatic potentials because they did not converge into a single 
family of structures. The Coulombic electrostatic interaction energy is −120 kcal/mol 
for the MxiH dimer and −23 kcal/mol for the PrgI dimer. Molecular graphics were 
made using PyMol (A and B) and Dino (DINO: Visualizing Structural Biology 
(2002). http://www.dino3d.org) (C and D). The N- and the C- termini and the PxxP 
loop are indicated.16 
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CHARMM. Only the electrostatic potentials of residues involved in the packing 
interaction are shown in Figure 3-11C and D. The electrostatic maps of MxiH in 
Figure 3-7C and Figure 3-11C are not identical because the former was calculated 
from an isolated MxiH structure and the later was that of MxiH in the assembled 
needle after energy minimization, which changed the side-chain orientations to 
reduce the steric clash and optimize the MxiH–MxiH contacts in the needle. Thus, the 
relative side-chain coordinates of MxiH in Figure 3-7C and Figure 3-11C are not 
identical, and their electrostatic surfaces will not be identical as well. Similarly, the 
electrostatic maps of the isolated PrgI (Fig. 3-7A) and that of PrgI in the assembled 
needle after energy minimization (Fig. 3-11D) will not be identical. 
For MxiH, there is complementarity between the positively and the negative 
charged electrostatic surfaces of two MxiH molecules (Fig. 3-11C), whereas, PrgI 
showed mostly positive-to-positive electrostatic contacts (Fig. 3-11D). In addition, 
the calculated Coulombic electrostatic interaction energy of the MxiH dimer (Fig. 3-
11C) was five times lower than of the PrgI dimer (Fig. 3-11D). Although the packing 
interactions should be considered in the context of the entire needle, our modeling 
suggests that the interaction between PrgI molecules would have to be different from 
that of MxiH to maximize the complementarity between the positive-to-negative 
electrostatic contacts. Therefore, we conclude that the needle packing interaction in S. 
typhimurium would have to be different from that of S. flexneri, even though their 
needle monomers share 63% primary sequence identity, because the electrostatic 




This work would not be possible without the help of Thenmalarchelvi 
Rathinavelan and Wonpil Im, and they built the S. flexneri needle using the published 
crystal structure of MixH monomer13 and needle packing parameters36; 37. 
Thenmalarchelvi Rathinavelan and Wonpil Im also performed the electrostatic 
analysis of both MxiH and PrgI dimers. 
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Table 3-S1. NMR experimental detailes for PrgICΔ5. 
NMR experiment Bruker Pulse 
Sequence 
Experimental Details Time* 
2D HSQC hsqcfpf3gpphwg 8 NS* 2048×128 (N) pts 20 min 
2D HMQC blhmqcnoesy2d 8 NS 2048×256(C) pts 1h 30min 
3D HNCA hncagpwg3d 16 NS 2048×54(N)×100(C) 
pts 
1d 4h 
3D CBCA(CO)NH cbcaconhgpwg3d 16 NS 2048×54(N)×100(C) 
pts 
1d 6h 
3D HNCO hncogpwg3d 16 NS 2048×48(N)×50(C) 
pts 
13h 
3D HNCACB hncacbgpwg3d 40 NS 2048×50(N)×100(C) 
pts 
2d 19h 
3D HBHA(CO)NH hbhaconhgpwg3d 16 NS 2048×50(N)×96(H) 
pts 
1d 2h 










rdhsqcnoef3gpsi 24 NS 2048×360(N) pts 19 h 
 
NS*: number of scans 











Figure 3-S1. Portion of the 3D HNCA strips of 13C, 15N-labeled PrgICΔ5, shown as 
13C, 1H strips for Ser62-Lys66 (the 15N ppm is on the Z-axis). Each strip shows the Cα 
of the preceeding and current residue and the amide (1H and 15N) resonances of the 
current residue, indicating a sequence specific connectivity between these strips. The 
HNCA data was used together with 15N-HSQC-NOESY, CBCA(CO)NH and 
HNCACB to complete backbone assignment of PrgICΔ5. 
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Figure 3-S2. Portion of the 3D HNCACB strips of 13C, 15N-labeled PrgICΔ5, shown as 
13C, 1H strips for Ser62-Lys66 (the 15N ppm is on the Z-axis). Each strip shows the Cα 
and Cβ of the preceeding and current residue and the amide (1H and 15N) resonances 
of the current residue, indicating sequence specific connectivity between these strips. 
The Cα and Cβ have opposite phases (shown as black and red peaks). In theory, the 
3D HNCACB dataset contains all the information needed in assigning all the 
backbone resonances of a protein. However, this experiment is insensitive, and was 
used in combination with the more sensitive HNCA, 15N-HSQC-NOESY and 
CBCA(CO)NH experiments to complete the backbone assignments of PrgICΔ5. 
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Figure 3-S3. Portion of the 3D 15N-HSQC-NOESY strips of 15N-labeled PrgICΔ5, 
shown as 1H, HN strips for Ser62-Lys66 (the 15N ppm is on the Z-axis). Each strip 
shows all the backbone HN NOE peaks including its own HN and the HNs of the 
preceding and following residues, indicating sequence specific connectivity between 






Figure 3-S4. Portion of the 3D HBHA(CO)NH strips of 13C, 15N-labeled PrgICΔ5, 
shown as 1H, 1H strips for Ser62-Lys66 (the 15N ppm is on the Z-axis). Each strip 
shows the Hα and Hβ of the preceeding residue and the amide (1H and 15N) resonances 
of the current residue. The HBHA(CO)NH dataset was collected to assist in the 
assignment of side chain resonances together with 2D 1H, 13C-HMQC and 3D 13C-








Figure 3-S5A. 2D 1H, 13C-HMQC spectra of 13C, 15N-labeled PrgICΔ5 in 100% D2O. 
The 3D 13C-HMQC-NOESY experiment was based on this 2D HMQC experiment 
and a third 1H NOE dimension was added. With the help of backbone assignment and 
3D HBHA(CO)NH, complete assignment of 2D 1H, 13C-HMQC and 3D 13C-HMQC-





Figure 3-S5B.  Methyl group region of 2D 1H, 13C-HMQC spectra of 13C, 15N-






Figure 3-S6. (A) The long-range NOE restraints (dark bars) are clustered in the in the 
α-helical regions of PrgI (V20-V65). The flanking regions (P4-G19 and K66-I75) 
have medium range (gray bars) and sequential (white bars) NOEs. (B) The well 
defined two-helix bundle in the middle of PrgI (helix α1 and α2) has the characteristic 
α- helical NOE patterns. The N-terminal region (P4-G19, shaded) also contain 








Figure 3-S7. Assay of the ability of Salmonella to invade Henle 407, a cultured 
human epithelial cell line. (A) Wild type bacteria can assemble functional needles and 
therefore can invade and be internalized by Henle 407. (B) Salmonella with a prgI 
null mutation cannot form functional needles and therefore cannot invade Henle 407, 
and thus can be washed away and killed with the antibiotic gentamycin. (C) Bacteria 
that had been internalized by Henle 407 are protected from gentamycin, and these 
bacteria can be freed later by a mild lysis procedure which disrupts the Henle 407 
cells but not the bacteria. (D) The number of freed bacteria is estimated by serial 
dilution and plating, and the number of bacterial colonies formed provides a measure 
of the invasiveness of S. typhimurium. A plasmid that expresses PrgI can restore the 
invasiveness of the prgI null mutant and PrgI mutations are introduced in this plasmid 
to correlate the functional relevance of the NMR structure of PrgI with respect to the 








Figure 3-S8. 2D HSQC spectra of two BsaL constructs BsaLCΔ5 and BsaLNΔ25 used 
for BsaL monomer-monomer interactions. BsaLNΔ25 was soluble and the most of the 
peaks in the spectra were overlapped with BsaLCΔ5, showing BsaLNΔ25 has the same 
overall structure as BsaLCΔ5. Many of the specific assignments of BsaLCΔ5 can be 





Figure 3-S9. (A)Titration of 15N-BsaLCΔ5 with increasing amounts of unlabeled 
BsaLNΔ25. Overlay of two 2D HSQC spectra at two BsaLNΔ25:BsaLCΔ5 molar ratios 
(black, 0 and red, 8). Most of the residues showed shifts upon dilution, indicating 
protein-protein interaction. (B) Surface representation of residues that showed 
chemical shift changes upon BsaL-BsaL interaction. Residues Asn33, Leu36, Gln40, 
Met60 and Tyr63 highlighted in blue clustered at one face of the BsaL structure. (C) 
Chemical shift differences for BsaLCΔ5 upon addition of unlabeled BsaLNΔ25. The 
chemical shift differences were calculated according to the formula Δδav = 
√((ΔδHN)2/2 + (ΔδN/5)2/2), where ΔδHN and ΔδN are the amide proton and nitrogen 
chemical shift differences, respectively. The X-axis is the residue number and the Y 
axis is the chemical shift differences Δδav (ppm). Only backbone amides are shown 
and calculated for chemical shift differences with the missing values being due to 








The atomic structures of needle proteins have provided a wealth of 
information in explaining biological data related to the phenotypes of needle protein 
mutants;1; 2; 3; 4; 5 however, empirical data on how needle monomers interact with each 
other during needle assembly are still lacking. Furthermore, whether the type III 
secretion needle is structurally altered during the protein secretion process is still 
unclear. Efforts on the crystallization of the fully assembled needle remain infeasible 
due to the non-uniformity in needle length, both for isolated needles and needles 
reconstituted in vitro.6  
An atomic model of the S. flexneri needle was described at 16 Å resolution 
using the X-ray fiber diffraction and EM-derived needle helical parameters and the 
crystal structure of the MxiHCΔ5 monomer.3; 7 However, information on both the 
MxiH N-terminal 19 residues and C-terminal 5 residues are unclear in the model and 
it was suggested that the N-terminal residues form a regular α-helix that line inside 
the needle channel which might have direct contacts with proteins traveling through 
the needle.3 It was proposed that the transmission of the invasion signal from the tip 
to the base might rely on the reorientation of the needle subunits.3 The protein side 
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chain orientation, however, is not accurately determined, which makes studies of 
subtle structural changes occurring in the needle difficult.  
In this chapter, we describe the characterization of the needle monomer-
monomer interactions by NMR spectroscopy. It will be shown that PrgICΔ5 is not 
completely monomeric in solution and there are residual interactions among PrgICΔ5 
monomers. The residues involved in PrgI-PrgI interaction are clustered mainly on the 
head group including the central PxxP motif, together with a few key residues on both 
helices (α1 and α2). In addition, the heteronuclear 1H-15N NOE data shows that both 
termini of PrgICΔ5 are in intermediate rigidity which suggests that partially structured 
regions might form rigid structures upon protein-protein interaction.  
 
MATERIALS AND METHODS 
Protein Expression and Purification  
To obtain soluble forms of PrgI, five residues at the carboxyl terminus were 
deleted to prevent aggregation, giving rise to PrgICΔ5 as described in chapter 3. 
Another soluble form of PrgI, GB1-PrgIFL, was constructed by attaching a solubility 
tag GB1 (B1 domain of Streptococcal protein G) followed by a TEV (tobacco etch 
virus) protease cleavage site, at the amino terminus of PrgI as described (Dalian et al. 
in preparation). Isotopically (15N) labeled protein was overexpressed in Escherichia 
coli BL21(DE3)(DNAY) grown in 1 liter of M9 minimal medium with 1g/L 15N 
ammonium chloride (Cambridge Isotope Laboratories, Inc.). Bacteria were grown at 
37˚C until midlog phase, induced with 1 mM IPTG (isopropyl-β-D-
 90
thiogalactopyranoside) and incubated in 15˚C shaker overnight. The bacterial cells 
were collected, resuspended in 30 ml of binding buffer (20 mM Tris-HCl, pH 8.0, 500 
mM NaCl, 5 mM imidazole) and lysed by sonication. The bacteria cell lysate was 
centrifuged at 22,500 g for 15 min, and the supernatant was loaded onto a Ni2+ 
affinity column (Sigma). The recombinant protein was purified by nickel affinity 
chromatography as described.4 The His6-GB1 tag was cleaved by adding 0.08 mM 
(volume percentile around 4%) TEV protease into purified GB1-PrgIFL and dialyzing 
the mixture in 8000 molecular mass cut-off dialysis tubing in buffer (50 mM Tris-
HCl, pH 8.0, 20 mM NaCl, 0.5 mM EDTA, 1 mM dithiothreitol) for 16 hours at room 
temperature. The TEV cleaved protein sample was further dialyzed into binding 
buffer and purified using Ni2+ affinity column. All the purified protein samples were 
concentrated using Amicon ultracel-3k (Millipore) and then dialyzed into NMR 
buffer (10 mM sodium phosphate, pH 6.5, 10 mM NaCl) before use and the protein 
concentration was estimated using absorbance at 280 nm.  
 
NMR Spectroscopy 
Uniformly 15N-labeled PrgICΔ5 and unlabeled GB1-PrgIFL were dissolved in 
NMR buffer as described above. NMR data were acquired at 25°C using a Bruker 
Avance 800 MHz spectrometer equipped with a cryogenic Z-axis pulse field gradient 
probe. The sequential backbone assignments of 13C, 15N-labeled GB1-PrgIFL (Fig. 4-
S1A and S1B) and 13C, 15N-labeled GB1-BsaLFL (Fig. 4-S2A and S2B) were obtained 
using the following triple-resonance experiments: HNCA8 and CBCA(CO)NH8. In 
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the heteronuclear 1H-15N NOEs experiment, relaxation recycle delays of 5 seconds 
before the 1H saturations of 3 seconds were applied (Table 2-S1 and 3-S1).9; 10; 11 
Chemical shift mapping experiment was done by acquiring a series of 2D 1H-15N 
HSQC spectra for each titration point. NMR data were processed using NMRPipe12 
and analyzed using NMRView13. The concentration of purified 15N-PrgICΔ5 and 
unlabeled GB1-PrgIFL were estimated by UV absorbance at 280nm to be 0.97 mM 
and 0.54 mM, respectively. In order to exclude the interference of concentration 
effect, the chemical shift mapping experiments were done using fixed amount of 15N- 
PrgICΔ5 and mixing with various amount of unlabeled protein GB1-PrgIFL in different 
NMR tubes and by compensating the volume using NMR buffer at different GB1-
PrgIFL:PrgICΔ5 volume ratios of 1:0, 1:1, 1:3, 1:6 and 1:11. For the 15N-PrgICΔ5 
dilution experiment, the protein was simply diluted at different dilution factors of 0, 
3, 5 and 12.  In order to test the function of PrgI C-terminal 5 residues, another 
titration was done using 15N-GB1-PrgIFL upon addition of unlabeled PrgICΔ5 at 
PrgICΔ5:GB1-PrgIFL molar ratios of 0 and 8.1. In order to exclude the concentration 
effect of GB1-PrgIFL, the concentration of 15N-GB1-PrgIFL was kept the same in all 
smples used in the titration. The dilution of the C-terminal deletion mutant 15N-
PrgICΔ10 into NMR buffer was done at dilution factors of 0 and 10. Prior to titration, 
all the purified protein samples were dialyzed into the same buffer to assure that the 
chemical shift changes were only due to protein-protein interactions and not to 
changes in solution condition upon mixing.  
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Mutagenesis of prgI  
  The prgI site specific mutations were introduced by PCR using the Stratagene 
Quickchange kit in two plasmids: (i) pET-22B-prgICΔ5, used to overexpress 
recombinant His-tagged PrgICΔ5 in E. coli BL21(DE3)(DNAY) cell, and (ii) pRK2-
prgI, used to express full length PrgI for Salmonella invasion assays (see below).  All 
mutations were confirmed by DNA sequencing.   
 
Paramagnetic Spin Labeling Experiment 
The cysteine-specific spin labeling probe 4-Maleimido-TEMPO (Sigma) was 
attached to the PrgICΔ5 N-terminal cysteine mutant N3C. There is no cysteine residue 
in PrgICΔ5, so the N3C cysteine mutant was introduced using the Statagene 
Quickchange kit. The purified PrgICΔ5N3C formed dimers in solution and 10 mM 
DTT was added and incubated overnight to reduce the disulfide bond. The protein 
was dialyzed into NMR buffer (10 mM sodium phosphate pH 6.5 and 10 mM NaCl) 
before spin labeling.14 The preparation of the spin-labeled protein was as follows: 
~0.4 mM 15N-PrgICΔ5-N3C was incubated with 10-fold excess of 4-Maleimido-
TEMPO at room temperature for 30 min.14 The reaction was quenched by the 
addition of 10 mM β-mercaptoethanol, and the spin-labeled protein was purified 
using a NAP-5 column Sephadex G-25 (GE Healthcare) to remove excess spin probe. 
NMR data was collected using a regular 1H, 15N-HSQC pulse sequence for the spin-
labeled and unlabelled proteins. The peak intensities were compared between spin 





After completion of the NMR structure of Salmonella PrgICΔ5 monomer4, the 
question addressed is how needle monomers interact with each other during needle 
assembly. NMR chemical shift mapping was used to identify PrgI residues that are 
involved in needle monomer-monomer interactions. A soluble form of full-length 
PrgI was made by fusion with a solubility tag, the GB1 domain, to the N-terminus of 
the needle protein PrgI. The GB1 tagged full-length PrgI, GB1-PrgIFL, is highly 
soluble in solution.  
Chemical shift mapping used in characterizing protein-protein interactions 
involves titration of an unlabeled protein into a 15N-labeled protein partner. Peak 
shifts in the 2D 1H, 15N-HSQC spectra upon titration indicates possible interaction. 
Surprisingly, when 15N-labeled PrgICΔ5 were titrated with unlabeled proteins or with 
NMR buffer, similar peak shifts were observed (Fig. 4-1A), indicating these peak 
shifts resulted from the perturbation of the protein-protein interaction among PrgICΔ5 
monomers. This residual interaction among soluble PrgICΔ5 monomers could be 
attenuated by increasing ionic strength, for example, by increasing salt concentration 
from 0 mM to 150 mM. Consistent with the results of chemical shift mapping, 
paramagnetic spin labelling data showed that the N-terminal spin probe also affected 
not only residues close to the N-terminus of PrgI but also residues on the helix α1 far 




Figure 4-1A. (A) Dilution of 15N-PrgICΔ5 with increasing amounts of NMR buffer. 
Overlay of four 2D HSQC spectra at various dilution factors (black, 0; red, 3.0; 
green, 5.0; blue, 12.0). Most of the residues showed shifts upon dilution. (B) Titration 
of 15N- PrgICΔ5 with increasing amounts of unlabeled GB1-PrgIFL. Overlay of five 2D 
HSQC spectra at various GB1-PrgIFL:PrgICΔ5 molar ratios (black, 0; red, 0.56; green, 
1.67; blue, 3.34; magenta, 6.12). Clear shifts were observed upon addition of 
unlabeled GB1-PrgIFL and the peaks shifted in the totally opposite direction with the 
shifts observed in dilution experiment. Peaks of individual residues G7 and D40 
showing shifts are zoomed in and pointed out for clarity.  
 
 
Figure 4-1B. Chemical shift differences for (A) PrgICΔ5 upon addition of unlabeled 
GB1-PrgIFL and (B) titration of buffer comparing two different titration points with 
BsaLCΔ5:GB1-PrgIFL molar ratios of 0 and 6.12 and dilution factor of 0 and 10. The 
chemical shift differences were calculated according to the formula Δδav = 
√((ΔδHN)2/2 + (ΔδN/5)2/2), where ΔδHN and ΔδN are the amide proton and nitrogen 
chemical shift differences, respectively. The X-axis is the residue number and the Y 
axis is the chemical shift differences Δδav (ppm). Only backbone amides are shown 
and calculated for chemical shift differences with the missing values being due to 




Figure 4-1C. Surface representation of the residues of PrgICΔ5 (shown in blue) that 
are perturbed upon PrgI-PrgI interaction. The residues don’t cluster into one site and 
the PrgI-PrgI interaction is involved almost all the parts of PrgI, possibly C-terminal 5 




Figure 4-2. The peak intensity ratio of spin labeled versus unlabeled 15N-PrgICΔ5-
N3C mutant. Due to the paramagnetic effect, peak intensity of residues close to the 
N-terminus was affected by the spin label. In addition to that, a stretch of residues 
close to C-terminus (F68-D72) were also affected. Side chains of some residues 
Gln24, Gln26 and Asn55 (shown in red) were greatly affected by the spin probe. 
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the PrgI-PrgI interaction. The spin labeling data also showed that there is a dip around 
residue Phe68, indicating C-terminal tail, especially the region around Phe68, is close 
in distance with the N-terminus (Fig. 4-2). In order to observe real peak shifts for 
itrations between PrgICΔ5 and other proteins, the residual interaction among PrgICΔ5 
molecules (concentration effect) must be excluded. This concentration effect was also 
observed for MxiHCΔ5 (Fig. 4-S3) but not BsaLCΔ5 (Fig. 4-S4).  
   
PrgICΔ5 Residues Perturbed in PrgI-PrgI Titrations 
In order to exclude the concentration effect, we carefully kept the same 
concentration of 15N-labeled PrgICΔ5 and varied the amount of unlabeled GB1-PrgIFL 
in each titration point. The 2D 1H-15N-HSQC spectra show that a subset of the 
backbone and side-chain amide resonances progressively shift upon addition of 
increasing amount of unlabeled GB1-PrgIFL (Fig. 4-1A). Small shifts of those 
perturbed residues imply that the interaction between PrgI monomers is in fast 
exchange NMR time scale, and weak interaction in the order of 0.7 mM (Fig. 4-3). 
The PrgICΔ5 dilution with NMR buffer also showed a weak PrgI-PrgI interaction, 
however, in a relative higher affinity in the order of 0.07 mM. Additionally, it was 
noticed that the peaks shifted in the opposite direction relative to the data of PrgICΔ5 
titrated with GB1-PrgIFL compared with the PrgICΔ5 dilution data (Fig. 4-1B). 
Considering the opposite titration effect on the total protein concentration of different 
forms of soluble PrgI, results of these two datasets are consistent. Similar results were 
shown by analysis of the chemical shift differences of these two datasets (Fig 4-1B).  
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Figure 4-3. Simultaneous fit performed on chemical shift perturbations of 2 residues 
(Gly7 and Asp40) backbone and 1 residue (Gln24) side-chain HN cross-peaks in the 
PrgICΔ5:GB1-PrgIFL titration according to the various concentrations of unlabeled 




where Pt, Lt, KD and Bmax are the concentration of protein titrated into, the protein 
concentration of prtein titrated with, dissociation constant, and the chemical shift 
deviation at saturation, respectively. 
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We found that the PxxP motif residues Ser39 and Asp40 which showed 
significant chemical shift changes are most likely involved in PrgI-PrgI interaction. 
Residues close to the PxxP motif (Ala30, Asp32, Lys33, Lys37, Ala42, Ala46, Ser49 
and Lys50) also showed significant chemical shift changes (Fig. 4-1B). These 
residues clustered on a surface of the PrgI head group (Fig. 4-1C). In the second helix 
of PrgI, a series of residues including Ser52, Tyr57, Arg58, Lys66, Val67 and Phe68 
also showed relatively significant chemical shift changes, indicating that these 
residues on the second helix are involved in the PrgI monomer-monomer interaction. 
The side chain of residue Gln24 showed the most significant chemical shift change, 
but Gln24 is not included in any group of residues mentioned above. It was surprising 
that N-terminal residues Gly7 and Leu9 also showed significant changes in the 
titration. These results suggest more than one binding site is involved in the PrgI 
monomer-monomer interaction. 
A C-terminal deletion of 10 residues was made, PrgICΔ10, and examined to 
characterize the residual interaction (Fig. 4-4A). The dilution of 15N-PrgICΔ10 with 
NMR buffer showed head group residues (Ala30, Lys33, Ser39 and Asp40) close to 
the PxxP motif still showed concentration effect and these residues are involved in 
the residual PrgICΔ10 monomer interactions (Fig. 4-4B). However, residues Gly7 and 
Leu9, close to the N-terminus, and residues Lys66, Phe68, close to the C-terminus, 
coincidently showed small shift change differences compared to the PrgICΔ5 dilution, 
suggesting possible interactions among those two stretches of residues (Fig. 4-4B). 
This is consistent with the spin labeling data described above (Fig. 4-2). 
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Figure 4-4A. Dilution of 15N-PrgICΔ10 with increasing amounts of NMR buffer. 
Overlay of two 2D HSQC spectra at various dilution factors (black, 0 and red, 10.0). 
Most of the residues showed peak shifts upon dilution. 
 
 
Figure 4-4B. Chemical shift differences for PrgICΔ10 upon dilution with buffer at 
dilution factor of 0 and 10. The chemical shift differences were calculated as 
described in the Material and Methods section and plotted on the y-axis. Backbone 
amides (shown in black) are shown, and the side chain of residue Gln24 (shown in 
red) showed significant chemical shift difference. Missing values are due to 
incomplete assignments or overlapped peaks.  
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Heteronuclear 1H-15N NOE of PrgICΔ5 and BsaLCΔ5 
Previous NOE data suggest both the N- and C- termini of PrgI adopt weak α-
helical character, which is consistent with the low convergence of the NMR structures 
for the N- and C-termini.4 Steady-state heteronuclear 1H-15N NOE was used to 
quantify the degree of internal protein dynamics by the analysis of the fast motions of 
protein backbone dynamics in nano-second to pico-second range.  The core domain 
two helices showed heteronuclear 1H-15N NOE values (>0.7) which indicates rigid 
structure. The relatively low heteronuclear 1H-15N NOE values (0.4< NOE <0.6) of 
both the termini imply they are in medium range mobility (Fig. 4-5A). Here, the N-
terminus boundary defines residues from Tyr8 to Asn22 and C-terminus boundary 
defines residues from Gln61 to the end of the protein. Similarly, both termini of 
BsaLCΔ5 also adopt medium range rigidity (Fig. 4-5B). 
 
DISCUSSION 
PrgI is a small acidic protein that can self-associate into an ordered needle 
structure on the Salmonella surface. It was previously determined that deletion of C-
terminal 5 residues prevented the aggregation of PrgI (PrgICΔ5 is soluble and 
monomeric in solution).4 However, peak shifts were observed in the PrgICΔ5 dilution 
experiment, suggesting there is residual interaction between PrgICΔ5 monomers. The 
previously reported Shigella needle model showed there are 7 identical MxiH 




Figure 4-5A. Heteronuclear 1H-15N nuclear Overhauser enhancement of PrgICΔ5. 
Small or negative values indicate a high degree of flexibility. The horizontal bar at 
0.4-0.6 marks an approximate boundary between flexible (below) and rigid (above) 
amides on a subnanosecond time scale. 
 
 
Figure 4-5B. Heteronuclear 1H-15N nuclear Overhauser enhancement of 
BsaLCΔ5. Small values indicate a high degree of flexibility. The horizontal bar at 0.4-
0.6 marks an approximate boundary between flexible (below) and rigid (above) 
amides on a subnanosecond time scale. 
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the needle monomer-monomer interaction.3 The NMR chemical shift mapping data of 
titrating PrgICΔ5 with GB1-PrgIFL suggests that the PrgI head group residues, 
including the PxxP motif, along with some residues on both helices, are involved in 
the needle monomer-monomer interaction. These residues are not clustered in more 
than one binding sites, indicating that multiple sites are likely to be involved in this 
protein-protein interaction. Many of the perturbed residues are charged residues, 
suggesting electrostatic interaction could be important in PrgI-PrgI interaction. 
Additional hydrophobic effect might contribute to this interaction as well because a 
few hydrophobic residues were also perturbed in the titration data. Our mapping data 
also show that PrgI monomer-monomer interaction in vitro is weak. In the assembled 
needle, the high local concentration of needle monomers probably compensates for 
the weak interaction observed in vitro and it becomes strong enough to hold the 
needle monomers together. In order to achieve the fine control of needle assembly, 
strong interactions between needle monomers is probably not necessary. The weak 
interactions between PrgI monomers are corroborated by the low dissociation 
constants fitted using the data of PrgICΔ5 titrated with GB1-PrgIFL and PrgICΔ5 diluted 
with NMR buffer. Nevertheless, our data identified multiple binding sites involved in 
the weak PrgI-PrgI interaction, suggesting Salmonella needle is assembled by the 
binding of a single PrgI monomer with a number of other PrgI monomers, similar to 
the proposed Shigella needle model.3  
The relatively low heteronuclear 1H-15N NOE values show low rigidity of 
both the PrgI N- and C-termini, suggesting the two termini are somewhat flexible, but 
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not in random coil conformation (Fig. 4-5). These data were collected at high protein 
concentration and whether less concentrated protein which excludes PrgI-PrgI 
interaction will show a lower order of rigidity is worthy of pursuit. The model of the 
Shigella needle suggests well-structured α-helices at the N- and C- termini of MxiH.3 
Nevertheless, these findings are consistent with the partial α-helical NOE pattern of 
PrgI and imply there might be a thermodynamically favored conformation changes 
upon needle assembly.  
The C-terminal 5 residues of PrgI are important for the needle monomer-
monomer interactions and needle formation.1 It is not possible to use the PrgICΔ5 
construct to provide information on how C-terminal 5 residues are involved in the 
PrgI monomer-monomer interaction. Thus, a GB1 tag was used to solubilize the full 
length PrgI and both GB1-PrgIFL and PrgIFL-GB1 were shown to be highly soluble in 
solution, suggesting that bulky GB1 tag prevented the needle protein from 
aggregation. Both GB1-PrgIFL and PrgIFL-GB1 also showed concentration effect upon 
dilution, indicating that the GB1 tag might only disrupt some of the contacts that 
mediate the PrgI monomer-monomer interaction.  
The chemical shift mapping data of 15N-GB1-PrgIFL titrated with PrgICΔ5 
showed that C-terminal 5 residues did not lead to the same degree of peak shifts 
compared to the shifts seen for the head group residues (Fig. 4-6A and 6B). This 
suggests the C-terminal 5 residues might not play a dominant role in holding the 
needle monomers together as expected. Nevertheless, C-terminal 5 residues are still 




Figure 4-6A. Titration of 15N-GB1-PrgIFL with increasing amounts of unlabeled 
PrgICΔ5. Overlay of two 2D HSQC spectra at various PrgICΔ5:GB1-PrgIFL molar ratios 
(black, 0 and red, 8.1). Clear shifts were observed upon addition of unlabeled 
SipDNΔ38 and peaks of C-terminal residues I75, I76, Q77, N78, F79 and R80 are 




Figure 4-6B. Chemical shift differences for GB1-PrgIFL upon addition of unlabeled 
PrgICΔ5 comparing two different titration points at GB1-PrgIFL: PrgICΔ5 molar ratios 
of 0 and 8.1. The chemical shift differences were calculated as described. The X-axis 
is the residue number and the Y axis is the chemical shift differences Δδav (ppm). 
Only backbone amides are shown and calculated for chemical shift differences with 
the missing values being due to incomplete assignments or overlapped peaks. The last 
five residues (shown in red) were pointed out to show relatively small chemical shift 
difference. 
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among packed needle, suggesting the binding affinity among assembled needle 
monomers was dramatically decreased by the disruption of GB1 tag or C-terminal 5 
residue deletion. We completed the backbone assignment of GB1-PrgIFL including 
the C-terminal 5 residues. Further analysis of the Cα chemical shift difference 
between GB1-PrgIFL and PrgICΔ5 suggested GB1-PrgIFL adopted essentially identical 
structures as PrgICΔ5 (Fig. 4-S1A and S1B), implying that the C-terminal 5 residues 
are not sufficient in folding the N-terminal helix into a well formed helix by the 
interaction between two termini, and the N-terminal helix might rely on the inter-
molecular interaction to become folded. It is likely that the two flexible termini of the 
needle protein will undergo conformational changes from free soluble protein into 
ordered assembled needle and this conformation change might be thermodynamically 
driven. 
C-terminal 5 residue deletion is sufficient to prevent protein aggregation and 
needle assembly. It will be interesting to determine whether the N-terminus plays a 
similar role as the C-terminus. Thus, we made N-terminal deletion mutants, PrgINΔ5, 
PrgINΔ9, PrgINΔ12, and PrgINΔ16 and all purified proteins still slowly precipitated out of 
solution, implying the N-terminus might not be as important for needle packing 
compared to the C-terminal residues. It was shown, however, that residues Gly7 and 
Leu9 also have significant chemical shift changes in the titrations (Fig. 4-1B). These 
N terminal residues were also shown to have interactions with residues Lys66, Val67 
and Phe68 close to C-terminus in the PrgICΔ10 dilution data (Fig. 4-4B). The farthest 
long range 1H-1H NOEs from the PrgI two helices were between residues Phe16 and 
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Gln61. It is most likely that PrgI monomer-monomer interaction results in allosteric 
effects occurring at residues Gly7 and Leu9 through inter-molecular interactions. The 
N-terminal region might form an ordered α-helical structure upon needle assembly as 
proposed in the Shigella needle model.3 The highly flexible residue Gly7 might play a 
role as a hinge that attaches the first 6 residues (MATPWS) to the rest of the 
molecule. The formation of α-helical structure might affect the inner lining of the 
needle channel. Although it is likely that the N-terminus is involved in protein-protein 
interaction between the needle channel and proteins passing through the channel, no 
experimental data are currently available showing the N-terminus is involved in 
protein-protein interactions. 
The full length PrgI could be cleaved from purified GB1-PrgIFL by TEV 
cleavage, but the protein slowly precipitated and formed gel. We were able to collect 
the supernatant after centrifugation, and the resulting 2D HSQC showed different 
spectra from that of soluble PrgICΔ5, suggesting that full-length PrgI formed soluble 
aggreagates (Fig. 4-S5). Full length PrgI could also be purified in denaturing 
conditions (buffer that contains 6M urea). Once the urea was slowly dialyzed out, the 
protein formed white gel-like precipitate, especially when the urea concentration was 
lower than 1.0 M. Full length MxiH behaved similarly, however, full length BsaL is 
relatively soluble at low protein concentrations (0.1 mM) and 2D HSQC of full length 
BsaL shows essentially identical spectra compared to that of soluble BsaLCΔ5 (Fig. 4-
S2A), suggesting a unique behavior for BsaL. This is consistent with the observation 
that BsaLCΔ5 does not have concentration effect compared to PrgICΔ5 and MxiHCΔ5. 
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The N-terminal deletion construct BsaLNΔ25 also behaved differently compared to the 
PrgI N-terminal deletion construct, PrgINΔ16; and BsaLNΔ25 is highly soluble and 
monomeric in solution (Fig. 3-S8). These differences probably suggest BsaL might 
assemble differently with PrgI and MxiH. 
In order to probe how needles are packed together, further NMR 
characterizations including identification of distance restraints between needle 
monomers using NOE, RDC (residual dipolar coupling) and PRE (paramagnetic 
relaxation enchancement) restraints are needed. High resolution techniques like cryo-
EM or solid state NMR will also provide important information on the self-associated 
high molecular weight protein complex. Additionally, in vivo experiments to test the 
biological relevance of structural data are needed to achieve a better understanding of 
the needle assembly. We are going to perform Salmonella invasion assays on PrgI 
mutants and the deficiency of invasiveness will be further investigated by 
immunofluorescence staining of surface-exposed bacterial needle and transmission 
electron microscopy of the sheared needles from nonflagellated ΔflhC Salmonella 
typhimurium. The protein expression level and the secretion of proteins SipB and 
SipC into the culture supernatant will be tested by western-blot analysis. 
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Figure 4-S1A. 2D HSQC spectra of GB1-PrgIFL with sequence specific assignments 
of the last 10 residues. The assignments were finished based on 3D experiments: 3D 




















Figure 4-S1B. Difference between the Cα chemical shifts in PrgICΔ5 and Cα chemical 
shifts in GB1-PrgIFL. Nearly no difference for the PrgICΔ5 residues (black bars) was 
observed, indicating similar structure in both constructs PrgICΔ5 and GB1-PrgIFL. Only 
a few residues close to the C-terminal showed relatively higher chemical shift 
differences. The high chemical shift values (red bars) are due to the comparison of 









Figure 4-S2A. 2D HSQC spectra of BsaLFL with sequence specific assignments of 
the last 10 residues. The assignments were finished based on 3D experiments: 3D 













Figure 4-S2B. Difference between the Cα chemical shifts in GB1-BsaLFL and Cα 
chemical shifts in BsaLCΔ5. Nearly no difference for the BsaLCΔ5 residues (black bars) 
was observed, indicating similar structure between BsaLCΔ5 and GB1-BsaLFL. The 
high chemical shift values (red bars) are due to the comparison of different residues in 




Figure 4-S3. Dilution of 15N-MxiHCΔ5 with increasing amounts of NMR buffer (10 
mM Sodium Phosphate pH 6.5). Overlay of two 2D HSQC spectra at various dilution 







Figure 4-S4. Dilution of 15N-BsaLCΔ5 with increasing amounts of NMR buffer (10 
mM Sodium Phosphate pH 6.5). Overlay of two 2D HSQC spectra at various dilution 




Figure 4-S5. Overlay of 2D 1H, 15N-HSQC spectra of supernatant of PrgIFL gel-
forming sample (Black) with soluble PrgICΔ5 (Red). Lots of the PrgICΔ5 peaks did not 
overlay completely, suggesting different PrgI structural forms. 
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Chapter 5: Characterization of Needle-Tip (PrgI-SipD) Interaction 
 
INTRODUCTION OF TIP COMPLEX 
It was not until late 2005 that a TTSA tip complex composed of LcrV was 
reported at the tip of the Yersinia enterocolitica needle when the apparatus was in a 
resting state.1 This was quickly supported by showing that IpaD formed a tip complex 
for TTSAs in S. flexneri.2 It is proposed that the tip complex is needed to sense 
environmental signals and control the secretion and insertion of translocators into 
host membranes to initiate translocon pore formation3; 4; 5 In Shigella, once both 
translocator proteins IpaB and IpaC are recruited and inserted into the host cell 
membrane, a pore-like structure called the translocon is formed. Different effector 
proteins through the translocon pore are further injected directly into the host cell 
cytosol to disrupt normal cellular functions. Using atomic force microscopy, the 
translocon pore size of the translocon from different species was shown to vary from 
1.5 to 3.5 nm.6 Overall, the tip complex is believed to serve as a platform for the 
assembly of the translocon, which ultimately connects the bacterial pathogen to its 
eukaryotic host for the delivery of effector proteins.7 
Deletion of the first 20 residues of the IpaD prevents its secretion, suggesting 
that these residues act as a secretion signal.3 Deletions within the N-terminal third of 
the molecule do not affect invasion of host cells by the bacteria, although the 
insertion of IpaB/IpaC into membranes is slightly impaired.3 However, even short 
deletions (5 residues) in the C terminus of IpaD completely abolish the invasive 
 118
phenotype and pore insertion.3 These observations suggested that IpaD may play a 
role in regulating insertion of the IpaB/IpaC translocon pore from the tip of the S. 
flexneri needle.3 Sequence similarity suggests that SipD and BipD might play a 
similar role as IpaD.8 However, the effect of SipD-dependent control of effector 
secretion on Salmonella invasion has yet to be clearly described. 
Based on the sequence similarity, especially within their C-terminal 
sequences, tip proteins have been distinguished into two specific classes: (a) those of 
the SipD/IpaD/BipD family, and (b) those of the LcrV (Yersinia spp.)/PcrV 
(Pseudomonas aeruginosa) family.9 SipD, IpaD and BipD share ~30% primary 
sequence similarity and more than 90% similarity at the C-termini (Fig. 5-1), and 
very little with LcrV/PcrV. Biophysical data showed that all tip proteins possess the 
α-helical properties, which is consistent with the presence of a core coiled-coil in the 
X-ray structures (Fig. 5-2).9 Both SipD and IpaD showed two thermal transitions in 
CD denaturation experiments, suggesting the presence of two independently folded 
domains.9 This unique feature implicates distinct function of SipD and IpaD from 
other tip proteins.9  
The first reported high resolution structure of tip protein is the X-ray structure 
of monomeric LcrV (Fig. 5-2).10 LcrV has a dumbbell shape with a long central 
coiled-coil flanked by two globular domains.10 The long central coiled-coil was found 
to be a distinguishing feature of other tip proteins when the X-ray structures of BipD5; 
11 and IpaD5 became available. Both BipD and IpaD, however, possess larger N-




Figure 5-1. TTSS tip proteins of different bacteria show sequence conservation, 
especially within the C-terminal region. Highly conserved residues are colored red 
with the stretch conserved residues are boxed and identical residues are shaded red. 
The assigned secondary structure on top of the sequences is based on the crystal 
structure of IpaD. Sequences are from Swiss-Prot, and the bacterial species and its 
associated needle protein are: S. flexneri (IpaD), S. typhimurium (SipD) and 
B. pseudomallei (BipD). 
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domains of BipD and IpaD resemble the structure of the LcrV chaperonee LcrG since 
homologs of this chaperonee in Shigella and Burkholderia are absent and it has been 
suggested that IpaD and BipD may possess a self-chaperoneing ability.5  
Although the tip complex has been visualized at the tip of the needle,1; 2 how 
the tip protein assembles is not known. Based on immunoblotting and scanning-
transmission electron microscopy (STEM), it was suggested that three to five LcrV 
molecules were needed to form the tip complex of the Yersinia needle.12 Molecular 
modeling based on the crystal structures of LcrV and Shigella needle model 
suggested a pentameric LcrV tip complex.13 Likewise, molecular modeling based on 
the crystal structures of Shigella tip protein IpaD and its needle model suggested a 
pentameric IpaD tip complex.5 The tip proteins have not, however, been found to self-
assemble into pentamers in vitro during structure analyses which makes solving the 
the native tip complex more challenging. How the tip proteins interact with each other 
also remains to be determined. Caroline et al. were able to unfold the tip protein PcrV 
and LcrV by lowering the pH and the oligomeric species of tip proteins formed after 
refolding.14 However, key information about the difference between self-association 
form and monomeric form of tip proteins is absent. 
The positioning of the tip complex suggests that it interacts directly with the 
needle. Precisely how the tip proteins interact with needle monomers is currently 
unknown. The N-terminal domain of the IpaD tip protein has a two helix bundle that 
looks remarkably similar to the two helix bundle of the MxiH needle protein, 
suggesting a possible model for MxiH–IpaD interaction.15 A model suggests that  
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Figure 5-2. Ribbon structures of tip proteins (A) LcrV, (B) BipD, and (C) IpaD. 
Figures were generated using the following PDB IDs: LcrV, 1R6F; BipD, 2IZP; and 
IpaD, 2J0O.7 The central coiled-coil (gray) was flanked by two separate N-terminal 
and distal domains (green). 
 
Figure 5-3. A model of MxiH–IpaD interaction is based on the structural similarity of 
these proteins. (A) The MxiH two helix bundle (green) can be superimposed with the 
N- terminal domain of IpaD (gray) with a Cα root-mean-square deviation of 3.2 Å. 
(B) Likewise, the BsaL two helix bundle (green) can be superimposed with the N-
terminal domain of BipD.7 
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when IpaD is secreted and localized to the tip of the needle, its N-terminal domain 
swings away, leaving the binding interface of the long central coiled-coil accessible 
to MxiH.15 MxiH thus mimics the IpaD N-terminus and binds to the lower part of the 
IpaD long central coiled-coil (Fig. 5-3). It is likely that other tip proteins will bind 
their respective needle partners in a similar manner based on the following 
observations: (i) the two helix bundle of BsaL can be fitted with the N-terminal two 
helix bundle of BipD (Fig. 5-3); (ii) BipD is also capable of binding the MxiH needle 
of S. flexneri,5 and the C-terminal sequences of IpaD and BipD are similar. Likewise, 
the divergence of C-terminal sequences for the LcrV/PcrV family and their inability 
to be retained at the Shigella MxiH needle tip (unpublished data) are also consistent 
with this model of MxiH–IpaD interaction (Fig. 5-3). 
In this chapter, we show the characterization of the needle-tip interaction 
using NMR. We mainly focused on the interactions between PrgI and SipD (from 
Salmonella) and BsaL and BipD (from Burkholderia). Our titration data showed 
distinct binding sites of PrgI are involved in the PrgI-SipD interaction compared to 
the PrgI-PrgI interaction. It was also suggested that the interactions between the 
needle proteins and tip proteins are weak. Detailed understanding of the needle-tip 
interactions requires further determination of the high resolution structures of these 
complexes.  
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Part I: Characterization of PrgI bound to SipD 
 
INTRODUCTION 
The Shigella tip protein IpaD localizes on top of the Shigella needle and 
controls the secretion and insertion of translocator proteins IpaB and IpaC into the 
host membrane.2; 3 The tip protein SipD (Salmonella invasion plasmid antigen D) is 
likely to play a similar role. SipD was shown to be crucial for protein secretion and 
Salmonella invasion.8 It was suggested that tip proteins assemble on top of the needle 
and stabilized by the interaction between tip proteins and needle proteins.1; 13 A high 
resolution structure of SipD is unavailable; however, SipD shares high sequence 
conservation with IpaD whose structure is known.5 Using the structure prediction 
program I-TASSER, SipD is suggested to have a similar structure to IpaD. We solved 
the structure of the Salmonella needle protein PrgI by NMR and PrgI was shown to 
possess a helix-turn-helix structure with a central PxxP motif.16 The N- and C- 
termini flanking the core structure adopt partial helical structures. The individual 
high-resolution structures of IpaD, PrgI and the modeled structure of SipD have 
provided valuable information in understanding the function of these proteins. 
However, questions about the assembly mechanism of type III secretion tip complex 
at the needle tip still remain to be answered. 
Here, we describe the characterization of how the Salmonella PrgI (needle 
protein) interact with the SipD (tip protein). NMR chemical shift mapping was used 
to show that distinct PrgI residues were clustered and involved in the PrgI-SipD 
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interaction. The PrgI residues involved in the PrgI-SipD interaction are clustered on a 
large patch close to the C-terminus of PrgI. In addition, a couple of residues at the N-
terminus are also involved .Our data suggest that different subsets of PrgI residues are 
involved in needle assembly (PrgI-PrgI) and needle-tip (PrgI-SipD) interaction. 
Although the main focus in this chapter is the needle (PrgI) and tip (SipD) proteins of 
Salmonella, we also obtained data for the corresponding proteins for Burkholderia 
needle (BsaL) and tip (BipD) proteins to serve as experimental control. 
 
MATERIALS AND METHODS 
Protein Expression and Purification 
The SipD construct, SipDNΔ38, was designed based on the sequence homology 
between SipD and IpaD that showed the first 38 residues of SipD are disordered. In 
the crystal structure of IpaD, the N-terminal 38 residues of IpaD lacked of electron 
density and were essentially unstructured. The SipDNΔ38 gene was subcloned into the 
pET-21a (Novagen), which appends a His6 tag followed by a GB1 domain and a TEV 
protease cleavage site at the amino terminus. The BipD construct, BipD35-301, was 
designed based on its crystal structure (Fig. 5-1) which showed both terminal ends 
were disordered and thus were removed. The BipD35-301 gene was subcloned into 
pET-21a (Novagen), which also appends a His6 tag and a TEV protease cleavage site 
at the amino terminus. Isotopically (15N) labeled protein was overexpressed in 
Escherichia coli BL21 (DE3) (DNAY) grown in 1 liter of M9 minimal medium with 
15N ammonium chloride (Cambridge Isotope Laboratories, Inc.). The bacteria were 
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grown at 37˚C until mid-log phase, induced with 1 mM IPTG and incubated in 15˚C 
shaker overnight. The bacterial cells were harvested, resuspended in 30 ml of binding 
buffer (20 mM Tris.HCl (pH 7.9), 500 mM NaCl and 5 mM imidazole) and lysed by 
sonication. The recombinant proteins were purified by Ni2+ affinity chromatography 
as described.16 The His6-GB1 tag or His6 tag was removed by TEV protease cleavage 
from purified His6-GB1-(TEV)-SipDNΔ38 and His6-(TEV)-BipD35-301 respectively as 
described.17 The TEV protease cleaved proteins were further purified by passing 
through Ni2+ affinity column. All purified protein samples were concentrated using 
Amicon ultracel-3k when needed and dialyzed into NMR buffer (10 mM sodium 
phosphate, pH 6.5, 10 mM NaCl) before use, and the protein concentration was 
estimated using absorbance at 280 nm.  
 
NMR Spectroscopy 
Uniformly 15N-labeled PrgICΔ5 and unlabeled SipDNΔ38 were dialyzed in NMR 
buffer (10 mM sodium phosphate pH 6.5, 10 mM NaCl). NMR data were acquired at 
25°C using a Bruker Avance 800 MHz spectrometer equipped with a cryogenic Z-
axis pulse field gradient probe. NMR chemical shift mapping was done by acquiring a 
series of 1H-15N HSQC 2D spectra. NMR data were processed using NMRPipe 18 and 
analyzed using NMRView 19.  
 
NMR Chemical Shift Mapping 
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Purified recombinant 15N-PrgICΔ5 and unlabeled SipDNΔ38 were purified as 
described and the concentration is estimated by UV absorbance to be 280nm as 0.97 
mM and 0.72 mM, respectively. To eliminate the concentration effect, we perform the 
chemical shift mapping titrations using fixed amounts of 15N- PrgICΔ5 and mixing 
with various amount of unlabeled protein GB1-PrgIFL and SipDNΔ38 in different NMR 
tubes by compensating different amount of buffer with different protein volume ratios 
of 1:1, 1:3, 1:6 and 1:11. 15N-PrgICΔ5 dilution experiment was done by diluting the 
protein into different dilution factors of 0, 3, 5 and 12. Purified protein 15N-PrgICΔ5 
and SipDNΔ38 were dialyzed into the same buffer prior to titration to assure that the 
chemical shift changes were only due to protein-protein interactions and not to 
changes in solution condition upon mixing.  
 
RESULTS 
PrgICΔ5 Residues Perturbed in PrgI-SipD Titration 
The concentration of 15N-labeled PrgICΔ5 was kept identical in all titration 
points to eliminate the concentration effect during the titration of 15N-labeled PrgICΔ5 
with unlabeled SipDNΔ38 (Fig. 5-4A). Peak shifts were observed, but the chemical 
shift changes were smaller than the changes observed, albeit smaller than the 
chemical shift changes observed in the titrations for PrgI monomer-monomer 
interaction (Fig. 5-4A). The small chemical shift changes indicate weaker interaction 
between PrgI and SipD in the order of 1.0 mM, and the interaction is in fast exchange 
NMR time scale. The direction of the peaks shifts is in a different direction with  
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Figure 5-4A. Titration of 15N-PrgICΔ5 with increasing amounts of unlabeled SipDNΔ38. 
Overlay of five 2D HSQC spectra at various SipDNΔ38:PrgICΔ5 molar ratios (black, 0; 
red, 0.74; green, 2.23; blue, 4.45; magenta, 8.16). Peak shifts were observed upon 
addition of unlabeled SipDNΔ38. Peaks of specific residues G7, F68 and L76 that 
showed peak shifts are boxed and zoomed in (2x) for clarity. D40, which did not 
show peak shifts in the PrgI-SipD titration, but showed a significant peak shifts in the 




Figure 5-4B. Chemical shift differences for PrgICΔ5 upon addition of unlabeled 
SipDNΔ38 at two titration points with SipDNΔ38: PrgICΔ5molar ratios of 0 and 8.16. The 
chemical shift differences were calculated according to the formula Δδav = 
√((ΔδHN)2/2 + (ΔδN/5)2/2), where ΔδHN and ΔδN are the amide proton and nitrogen 
chemical shift differences, respectively. The x-axis is the residue number and the y 
axis is the chemical shift differences Δδav (ppm). Only backbone amides are shown. 
Missing values are due to incomplete assignments or overlapped peaks. 
 
Figure 5-4C. Surface representation of the residues of PrgICΔ5 (shown in green) that 
are perturbed upon PrgI-SipD interaction. The residues mainly cluster at the PrgI C-
terminal tail. Two residues at the PrgI N-terminal are also perturbed.  
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peaks shifts observed upon the dilution of PrgICΔ5 (Fig. 4-1A), indicating those 
chemical shift changes are due to the binding of SipD. Additionally, PrgICΔ5 peak 
broadening was observed upon addition of unlabeled SipDNΔ38, suggesting that 
protein-protein interaction was occurring. Similar to the PrgI monomer-monomer 
interaction, the N-terminal residues Gly7 and Leu9 also showed chemical shift 
changes in the PrgI-SipD titration (Fig. 5-4B and 4C). The C-terminal residues 
Lys66, Val67, Phe68, Lys69 and residues Asp72, Ala73, Leu76 and Glu77 of PrgICΔ5 
showed relatively significant chemical shift changes and these chemical changes are 
different from those seen in the PrgI-PrgI interaction (Fig. 5-4B and 4C).  
 
DISCUSSION 
The NMR chemical shift mapping data of PrgI-SipD titration show that 
distinct binding sites are involved in needle-tip interaction compared with the PrgI-
PrgI interaction. A stretch of residues close to the C-terminus, from Lys66 to Lys69 
and from Asp72 to Glu77, showed chemical shift changes upon PrgI-SipD binding, 
suggesting these residues are most likely affected by the PrgI-SipD interaction. 
Among these residues, Lys66, Val67, Phe68 were also shown to be involved in PrgI 
needle monomer-monomer interaction (Fig. 4-1B). N-terminal residues Gly7 and 
Leu9 also showed chemical shift changes, suggesting that the PrgI-SipD interaction 
also requires the PrgI N-terminus. Alternatively, it is also possible that the N-terminus 
is not the direct binding site and that the N-terminal residues (Gly7 and Leu9) 
experience allosteric changes upon the PrgI-SipD binding. The induced 
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conformational changes at the N-terminal region might affect the function of the 
several N-terminal PrgI residues, which might be important for the protein-protein 
interactions occurring between the needle protein and proteins traveling through the 
needle channel. A possible scenario in the binding interaction would be a change in 
the orientation of N-terminus of the needle protein which lines the inner needle 
channel, where the invasion signal might be transmitted from the tip to the bacterial 
basal body. Nevertheless, our chemical shift mapping data showed that unlike the 
needle monomer-monomer (PrgI-PrgI) interaction, the needle-tip (PrgI-SipD) 
interaction mainly involves the C-terminus of PrgI and probably the N-terminus of 
PrgI as well. To have a better understanding of the PrgI-SipD interaction, attempts to 
characterize how SipD binds to PrgI are still needed. 
Regarding the needle and tip proteins of Burkholderia, titration of 15N-
BsaLCΔ5 with unlabeled BipD35-301 showed no definitive binding interface of BsaL-
BipD interaction. The NMR titration data is consistent with the observation that 
interaction between PrgI and SipD are weak. Due to the structural role of both tip and 
needle proteins on the bacterial surface, it is possible that the local concentration of 
two proteins is high enough to compensate for the low binding affinity observed in 
vitro for isolated proteins. Therefore, a strong binding is not necessary and a fine 
regulation can be achieved by subtle structural changes upon binding. To achieve a 
better understanding of needle-tip interaction, PRE would be a useful alternative in 
studies of weak protein-protein interactions.  
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Part II: Characterization of Tip Protein Bound to Needle Protein  
 
INTRODUCTION 
After determining the binding interface of PrgI bound to SipD, we next 
addressed the question of how SipD binds to the needle protein. Compared to the 
relatively small needle proteins, the high molecular weight tip proteins pose 
additional challenges for NMR studies due to line broadening. Nevertheless, TROSY 
(Transverse Relaxation Optimized Spectroscopy), perdeuteration and specific 
labeling allowed the NMR resonance assignments of SipD.  
Here, we used NMR chemical shift mapping to characterize how the tip 
(SipD) protein interacts with the needle (PrgI) protein. The chemical shift mapping of 
SipD upon titration of PrgI revealed no conclusive peak shifts, suggesting weak 
interaction between SipD and PrgI. However, chemical shift changes were observed 
for Burkholderia tip (BipD) and needle (BsaL) proteins, despite similar weak 
interaction between BipD and BsaL. The key residues of BipD involved in binding 
BsaL will be revealed upon the completion of the sequence specific assignment of 
BipD.  
  
MATERIALS AND METHODS 
Protein Expression and Purification 
Perdeuterated 15N, 13C-labeled SipDNΔ38 and BipD35-301 samples were obtained 
by growing Escherichia coli BL21(DE3) in 1 liter of minimal media dissolved in 
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99.9% D2O and supplemented with 2 g/L of [13C]glucose and 1 g/L of 
[15N]ammonium chloride. The perdeuterated 15N, 13C-labeled growth was ~ 2 hours 
slower than normal 15N, 13C-labeled growth before the bacterial density reached 
A600~0.8. After induction, cell growth was continued at 15°C overnight and the A600 
barely reached ~2.0. Isotopically (15N) labeled SipDNΔ38 and BipD35-301 were 
overexpressed in Escherichia coli BL21 (DE3) (DNAY) grown in 1 liter of M9 
minimal medium with 15N ammonium chloride (Cambridge Isotope Laboratories, 
Inc.). The recombinant proteins were purified via Ni2+ affinity chromatography as 
described.16 The His6 tag was removed by TEV protease cleavage of purified His6-
GB1-(TEV)-SipDNΔ38 and His6-(TEV)-BipD35-301 as described.17 The protein samples 
were concentrated using Amicon ultracel-3k (Millipore) and dialyzed into NMR 
buffer (10 mM sodium phosphate, pH 6.5, 10 mM NaCl). Protein concentration was 
estimated using absorbance at 280 nm.  
 
Specific Amino Acid Labeling of Tip Protein 
To facilitate the resonance assignment of SipD and BipD, 10 specific 15N-
labeled amino acids were used, such as 15N-leucine, 15N-valine, 15N-isoleucine, 15N-
alanine, 15N-phenoalanine, 15N-glutamate, 15N-aspartate, 15N-tyrosine, 15N-methionine 
and 15N-lysine. The labeling of 15N-glutamate and 15N-aspartate, however, were 
unsuccessful due to scrambling of the 15N label into other types of amino acids 
because both glutamate and aspartate are involved in the biosynthesis of other amino 
acids. Nevertheless, excluding Glycines and Prolines, 47% of total SipD residues 
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(excluding Prolines and Glycines) and 50% of total BipD residues were specifically 
labeled with 15N-amino acids.  
An E.coli starter culture was first grown in 1 liter LB media overnight, and 
was centrifuged and transferred into 500 ml M9 minimal medium containing various 
amounts of 15N- and unlabeled amino acids in the media. After ~ 45 min 
equilibration, the bacteria were induced with 1 mM IPTG at A600 ~ 0.8 and cell 
growth was continued at 37 °C for 4 hours before harvest. The selective amino acid 
labeled recombinant proteins were purified same as unlabeled tip proteins as 
described above.  
 
NMR Spectroscopy 
NMR data were acquired at 30°C on a Bruker Avance 800 MHz equipped 
with cryogenic triple-resonance probes. Resonance assignments were obtained from 
2D 1H–15N TROSY-HSQC20 and the following 3D datasets: TROSY-HNCA,21 
TROSY-HNCACB22 and TROSY-HN(CA)CO22 using 0.46 mM perdeuterated 
15N,13C-SipDNΔ38 and 0.4 mM perdeuterated 15N,13C-BipD35-301 protein samples in 
NMR buffer (pH 6.5). NMR data were processed using NMRPipe18 and analyzed 
using NMRView.19  
 
NMR Chemical Shift Mapping 
Recombinant 15N-SipDNΔ38, 15N-BipD35-301, unlabeled PrgICΔ5 and BsaLCΔ5 
were purified as described and the concentration is determined by UV absorbance at 
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280 nm. NMR chemical shift mapping experiments were performed by acquiring 2D 
1H-15N TROSY-HSQC at PrgICΔ5:SipDNΔ38 molar ratios of 0 and 5. For BipD, NMR 
chemical shift mapping was performed at various BsaLCΔ5:BipD35-301 molar ratios of 
0, 0.27, 0.46, 0.92, 1.85 and 3.7. Both PrgICΔ5 and SipDNΔ38 or BsaLCΔ5and BipD35-301 
were dialyzed into the same buffer prior to titration to assure that the chemical shift 
changes were only due to protein-protein interactions.  
  
RESULTS 
BipD35-301 Residues Perturbed in BipD-BsaL Titration 
NMR chemical shift mapping was used to identify the BipD35-301 residues that 
bind BsaLCΔ5 because the interaction should result in chemical shift changes of 
BipD35-301 residues. We titrated 15N-labeled BipD35-301 with unlabeled BsaLCΔ5 and 
monitored the changes in the chemical shifts of BipD35-301 residues by acquiring a 
series of 2D TROSY-HSQC spectra with increasing amounts of BsaLCΔ5. Peak shifts 
were observed in the 2D HSQC of BipD35-301 upon titration of BsaLCΔ5 (Fig. 5-5). 
The peaks shifted in one direction upon titration of BsaLCΔ5 indicating that BipD-
BsaL interaction was in fast exchange NMR time scale, and weak interaction, in the 
order of 0.01 mM. Even when the molar ratio of BsaLCΔ5:BipD35-301 reached around 
4, the chemical shift changes were still relatively small, indicating weak interaction. 
However, the sequence specific assignment of BipD35-301 is still ongoing and the 





Figure 5-5. Titration of 15N-BipD35-301 with increasing amounts of unlabeled 
BsaLCΔ5. Overlay of six 2D HSQC spectra at various BsaLCΔ5:BipD35-301 molar ratios 
(black, 0; red, 0.28; green, 0.45; blue, 1.0; yellow, 1.8 and magenta, 3.7). Clear peak 
shifts of some BipD35-301 residues were observed upon addition of unlabeled BsaLCΔ5. 
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titration of mixing 15N-BipD35-301 with buffer was done at the dilution factor of 6 and 
no peak shifts were observed. 
 
SipD-PrgI Interaction  
We tried to use NMR chemical shift mapping to identify which SipD residues 
bind PrgI because our previous data showed that PrgICΔ5 residues were perturbed 
when titrated with to SipD, despite weak interaction. The SipD-PrgI titration was 
done by adding unlabeled PrgICΔ5 into 15N-labeled SipDNΔ38. The changes in the 
chemical shifts of SipDNΔ38 peaks were monitored by acquiring a series of 2D 
TROSY-HSQC spectra with increasing amounts of PrgI. However, no obvious peak 
shifts were observed even at PrgICΔ5:SipDNΔ38 molar ratio of 5 was reached (Fig. 5-6). 
A control titration of mixing 15N-SipDNΔ38 with buffer was done at a dilution factor of 
6 and no peak shift was observed either. 
 
Sequence Specific Backbone Assignment of SipDNΔ38 
We assigned the resonances of free SipDNΔ38 using a series of TROSY three-
dimensional NMR experiments with the help of the specific amino acid labeling of 8 
different amino acids (Fig. 5-7A). Assigning the NMR peaks of the 305-residue 
SipDNΔ38 was challenging because of the low sensitivity and poor resolution. 
SipDNΔ38 is predicted to be high α-helical, which is consistent with the presence of 
overcrowded peaks clustered withing a narrow proton chemical shift range. 






Figure 5-6. Titration of 15N-SipDNΔ38 with increasing amounts of unlabeled PrgICΔ5. 
Overlay of two 2D HSQC spectra at PrgICΔ5:SipDNΔ38 molar ratios (black, 0 and red, 





Figure 5-7A. Residues of SipDNΔ38 with backbone NMR assignments (shown in red, 
216 out of 295 backbone amides were assigned). The structure is a predicted SipD 
model using the program I-TASSER.23 Similar to IpaD structure, SipD is predicted to 
also adopte a dumbbell shape with a middle coiled-coil region that is flanked by two 






Figure 5-7B. Secondary chemical shifts obtained by substracting the random coil 
13Cα chemical shift values from those observed in the protein indicate the regions of 
α-helices and β-strands. The regions shadowed in green indicate the boundary of α-
helices and regions shadowed in red indicate the boundary of β-sheets in the 
predicted SipD model. Our secondary chemical shift index agrees with the predicted 
model and validates the model. 
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TROSY-HN(CA)CO, we assigned 216 of 295 (excluding the 10 prolines) backbone 
amides of SipDNΔ38. The secondary Cα chemical shift index analysis indicates that 
SipD is likely to have a similar secondary structure as the predicted I-TASSER model 
(Fig. 5-7B).23 We also collected the datasets for assigning BipD35-301, but the 
assignment of BipD35-301 are in slow progress due to the possible co-existence of both 
BipD35-301 monomer and dimer in the solution. 
 
DISCUSSION 
The recruitment of tip protein on the top of bacterial needle is critical for 
bacterial invasion.2 When the bacterial TTSA comes into direct contact with the 
cognate host cell,24 the translocators are immediately secreted and inserted into the 
host cell membrane. The two translocators then form a translocon pore, thus opening 
a direct channel through which bacterial effectors can be injected into the host cell 
cytosol in a one-step process.25 The Tip protein serves as a platform and is involved 
in multiple protein-protein interactions including needle-tip, tip-tip and tip-
translocator interactions. 
High solubility allows the biophysical and biochemical characterization of the 
tip proteins. Both SipD and BipD are soluble up to 0.7 mM without self-association 
or aggregating. Thus, it becames feasible to pursue studies of protein-protein 
interactions involving the tip protein by NMR spectroscopy. However, it is 
challenging for NMR studies of protein with more than 30 kDa, thus TROSY was 
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used to overcome this obstacle and TROSY versions of  three dimensional 
experiments used in backbone assignments worked relatively well for the tip proteins.  
 The available atomic structures of LcrV10, BipD5; 11 and IpaD5 show a high 
degree of α-helicity (Fig. 5-2). Similarly, SipD was also shown to be highly helical 
using CD spectroscopy.9 The overlapping of peaks in a very narrow range of proton 
chemical shift in 2D TROSY-HSQC spectra is consistent with the predominantly α-
helical structure of tip proteins (Fig. 5-5 and 5-6). The ambiguity of overlapped peaks 
of the helical region residues made sequence specific assignment of tip proteins 
relatively slow. Nevertheless, TROSY NMR methods combined with specific amino 
acid labeling resulted to assignment of over 70% of SipD residues. Most of the 
unassigned SipD residues belong to serine, glutamine or glutamate residues. The 
metabolic pathway of these three amino acids makes their specific labeling unlikely. 
Additional datasets including 3D and 4D experiments are needed in order to complete 
the assignment of SipD. The assignment of BipD is currently in progress. 
NMR chemical shift mapping of SipD upon addition of PrgI did not yield any 
peak shifts. The reason for this was probably due to the weak interaction between 
PrgI and SipD. In order to characterize this weak interaction, Paramagnetic 
Relaxation Enhancement (PRE) will be used to determine the interaction between 
SipD and PrgI. PRE is more sensitive compared to chemical shift mapping. NMR 
chemical shift mapping of BipD upon titration with BsaL showed obvious peak shifts 
(Fig. 5-5). The progressively small shifts on each titration point indicate that the 
interaction between BipD and BsaL was weak and in fast exchange NMR time scale. 
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Sequence specific backbone assignment of BipD will reveal the residues that are 
perturbed by BsaL binding and this will also provide valuable information in 
understanding the tip-needle interaction in other Gram-negative bacterial systems. 
PrgI mutants will be tested using fluorescence polorization to correlate the NMR data. 
Further investigation will be done by in vivo Salmonella invasion assays and 
immunofluorescence staining of surface-exposed TTSA tip complex using SipD 
antibody. Western-blot analysis will be used to test the protein expression level and 
the secretion of proteins SipD, SipB and SipC into the culture supernatant.  
 It is proposed that the tip protein undergoes conformational changes at the N-
terminal two helices, which swings away from the central coiled-coil and thereby 
allow binding to the needle protein.15 It is possible that upon the shift of the N-
terminal domain the tip protein will expose the surface which is important for the tip-
tip interaction. The assignments of SipD provide a wealth of information not only for 
characterizing the tip-needle and tip-DOC interactions, but also the potential 
interaction of tip-tip and tip protein and translocator protein.  
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Chapter 6: Characterization of SipD-Deoxycholate Interaction 
 
INTRODUCTION  
The maturation of TTS (type III secretion) was suggested to be a step-wise 
process.1 In Shigella, IpaD localizes to the tip of the Shigella needle and controls the 
secretion of translocators IpaB and IpaC.2 IpaD was further shown to respond to the 
DOC (deoxycholate) and other bile salts as well, to promote the stable recruitment of 
translocator protein IpaB to the needle tip without inducing a rapid burst of type III 
secretion.1 Only IpaB, not IpaC, was shown to colocalize with IpaD in the presence of 
DOC, suggesting that further recruitment of IpaC on the tip of bacterial needle 
requires further activation signal the type III secretion.1 This is consistent with the 
observation that the type III secretion is controlled by both IpaD and IpaB.1; 3 DOC 
bound to IpaD was shown to induce the bacteria into a secretion-competent state and 
may represent the first step of the step-wise maturation of the type III secretion..1 
Membrane protein IpaB was shown to bind with cholesterol4, and combining the fact 
that IpaB interacts with the host cell membrane lipid rafts enriched with cholesterols 
and sphingolipids at which the invasion occurs1; 5; 6, it is likely the IpaB will play a 
role to further activate the type III secretion. 
In Shigella, it is shown that bile salts induce the protein secretion and enhance 
the bacterial invasion.7 Opposite effect was observed that the Salmonella SPI-1 
invasion gene transcriptions were suppressed in the presence of Bile, and the 
Salmonella typhimurium invasion was greatly repressed.8; 9 Although information on 
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whether bile salt plays a similar role to activate the type III secretion in Salmonella 
remains unknown, it is suggested that the SPI-1 gene transcription would be 
derepressed and the type III secretion will be initiated in low bile concentration upon 
the bacterial penetration of the mucous layer.8 
DOC is shown to bind to IpaD and SipD. The fluorescence polarization data 
showed DOC binds to IpaD with around 10 μM disassociation constant, with a lower 
binding affinity with SipD. Using computer docking methods, DOC is suggested to 
bind IpaD along one side of the central coiled-coil that is close to the N-terminal two 
helix boundle (Fig. 6-S1).10 This model is consistent with the FRET (Förster 
Resonance Energy Transfer) data which suggests DOC binds close to the midpoint of 
the protein.10 The positioning suggests IpaB has directly contact with IpaD, however, 
no direct evidence has been shown that IpaB binds IpaD. It was suggested that DOC 
is bound by IpaD to induce a conformational change in IpaD, and this allows the 
secretion of IpaB, which is then bound to IpaD at the needle tip.1 The close 
evolutionary similarity between Salmonella and Shigella suggests a similar activation 
mechanism upon DOC binding. Membrane protein IpaB with a molecular weight of 
62 kDa makes the characterization of IpaD-IpaB interaction challenging. Currently 
available data suggest IpaB binds IpaD first, and then IpaC binds IpaB to form the 
translocon pore on the host cell surface.   
In this chapter, we characterized the SipD-DOC interaction using NMR 
chemical shift mapping. The DOC binding site of SipD was mapped to the bottom of 
the central coiled-coil and the long loop connected to the N-terminal domain, on the 
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opposite side of coiled-coil where locates the N-terminal two helices. This binding 
site, however, is different from the binding site obtained by computer simulation for 
IpaD-DOC interaction. This may suggest a different activation mechanism of type III 
secretion between Salmonella and Shigella, or probably reflects DOC binding to a 
weaker affinity site in SipD, and a strong affinity site in IpaD.10 Our data provide 
preliminary information for understanding the step-wise maturation of type III 
secretion secretion in Slamonella. 
  
MATERIALS AND METHODS 
Protein Expression and Purification 
Isotopically (15N) labeled SipDNΔ38 and BipD35-301 were overexpressed in 
Escherichia coli BL21(DE3)(DNAY) grown in 1 liter of M9 minimal medium with 
15N ammonium chloride (Cambridge Isotope Laboratories, Inc.). The recombinant 
proteins were purified via Ni2+ affinity chromatography as described.11 The His6 tag 
was removed by TEV protease cleavage of purified His6-GB1-(TEV)-SipDNΔ38 and 
His6-(TEV)-BipD35-301 as described.12 The protein samples were concentrated using 
Amicon ultracel-3k (Millipore) and dialyzed into NMR buffer (10 mM sodium 
phosphate, pH 6.5, 10 mM NaCl). Protein concentration was estimated using 




NMR data were acquired at 30°C on a Bruker Avance 800 MHz equipped 
with cryogenic triple-resonance probes. NMR data were obtained using 2D 1H–15N 
TROSY-HSQC experiment13. NMR data were processed using NMRPipe14 and 
analyzed using NMRView.15  
 
NMR Chemical Shift Mapping 
Recombinant 15N-SipDNΔ38 and 15N-BipD35-301were purified as described and 
the concentration is determined by UV absorbance at 280nm. The chemical shift 
mapping of DOC bound to tip proteins was done by dialyzing the 0.61 mM 15N-
SipDNΔ38 and 1.1 mM 15N-BipD35-301 into NMR buffer with 0M, 0.7 mM, 1.4 mM and 
2.1 mM DOC, respectively. Control titrations were done by titrating SipDNΔ38 and 
BipD35-301 with NMR buffer at the dilution factor of 6. 
 
RESULTS 
SipDNΔ38 Residues Perturbed in the SipD-DOC Titration 
It was shown that the bile salt deoxycholate (DOC) interacts with IpaD and 
SipD but not to BipD.10 We used NMR chemical shift mapping to identify the SipD 
residues that are perturbed upon titration with DOC. We dialyzed 15N-labeled 
SipDNΔ38 into NMR buffer with varying concentrations of DOC and monitored the 
changes in the chemical shifts of SipDNΔ38 by acquiring a series of 2D TROSY-HSQC 
at DOC:SipDNΔ38 molar ratios of 0, 1, 2 and 3. Peak shifts were observed in the 2D 




Figure 6-1. Titration of 15N-SipDNΔ38 with increasing amounts of deoxycholate 
(DOC). Overlay of four 2D HSQC spectra at various DOC:SipDNΔ38 molar ratios 
(black, 0; red, 1; green, 2 and blue, 3). Clear shifts of some SipDNΔ38 peaks were 
observed with increasing amount of DOC. 
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of DOC changed the peak positions even further in one direction, indicating that 
binding was in fast exchange NMR time scale.  
Using the sequence specific assignment of SipDNΔ38 described in Chapter 6, 
we were able to identify most the residues that were perturbed upon titration with 
DOC. Residues that showed chemical shift changes are Ser96, Phe109, Ser110, 
Ala111, Leu116, Phe117, Ala119, Gln124, Asp131, Glu133, Tyr149, Gln165, 
Leu179, Val187, Lys188, Val256, Gln306, Thr307 and Leu322. Along with residues 
that showed relatively small chemical shift changes: Ser98, Thr127, Ile142, Ala144, 
Ser148, Asn155, Ala158, Glu237, Leu238, Met282, Gln291 and Thr303. A binding 
site is located on the bottom of the central coiled-coil and the extended loop between 
the coiled-coil and the N-terminal domain, on the reverse side of the central coiled-
coil where the N-terminal two helices locate (Fig. 6-2). Although the atomic structure 
of SipD is unavailable, most of the residues on the DOC binding are clustered on one 
site, which suggests a clear binding site of SipD for DOC. As control, similar DOC 
titration was performed for BipD35-301, however, no obvious peak shifts were 




The tip protein was shown to assemble into a ring-like structure at the tip of 
the needle16 and recruitment of the tip protein is critical for the bacterial invasion.2 







Figure 6-2. Perturbed residues of SipDNΔ38 (shown as sticks) upon titration of DOC, 
using the predicted I-TASSER model.17 Residues labeled in red showed significant 
chemical shift changes and residues labeled in cyan showed relatively smaller 
chemical shift changes. A binding site for DOC clustered at the bottom of the coiled-
coil, on the reverse side of coiled-coil which has the N-terminal two helices.  
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translocator protein IpaB at the tip of the needle.1 This is the initial sensing of the 
environment signal for the activation of the type III secretion.1 It was suggested the 
IpaB acted as a sensor for further activation signal and was likely to bind to the host 
membrane and activate the type III secretion upon host cell contact.1; 18 However, 
further information on how IpaC is recruited and inserted into the host cell membrane 
still remains unclear. 
Although bile was shown to repress the type III secretion by suppressing the 
SPI-1 gene transcription, a similar activation mechanism was adopted by Salmonella 
upon DOC binding.8; 9 In vitro data showed that both IpaD and SipD were able to 
bind DOC.10 We used NMR chemical shift mapping to characterize the SipD-DOC 
binding, and the SipD-DOC interaction was shown to be weak. Using the known 
assignments of SipD that have been completed to date, we were able to identify 
residues that are perturbed upon the titration of DOC. These residues were clustered 
along one side of the central coiled-coil (Fig. 6-2), which is suggested to be the 
binding pocket for DOC. Due to incomplete assignment, not all of the residues close 
to the binding site were shown to have chemical shift changes. An earlier model 
proposed the binding site of IpaD with DOC is located at the reverse side of the 
coiled-coil and between the central coiled-coil and the N-terminal two helices.10 It 
was also found that DOC bound more tightly to IpaD compared to SipD, thus the 
binding site ascribed to the SipD-DOC interaction might represent the weaker affinity 
site of DOC.10 It will be interesting to determine the binding site of IpaD with DOC 
using chemical shift mapping experiment. There are some other perturbed residues 
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(Leu179, Lys188 and Met 282) located at the loop regions between distal domain and 
the central coiled-coil. The perturbation of these SipD residues is probably due to the 
induced conformational changes instead of direct contact with DOC. This 
conformational change might facilitate the subsequent sensing of the the type III 
secretion activation signal and a possible scenario could be that the distal domain 
swings away from the central coiled-coil which then facilitates the recruitment of 
translocator protein IpaB at the tip of the type III secretion needle. Domain dynamics 
of SipD upon binding to DOC will be characterized by NMR. The possible protein-
protein interactions between the tip protein and the translocator protein will be 
studied as well. Information of loop dynamics and the tip-translocator interaction will 
be useful for understanding the further recruitment of the translocator and the 
activation mechanism of type III secretion. 
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Figure 5-S1. Simulated docking of deoxycholate onto the crystal structure of IpaD is 
shown. (A) deoxycholate docked onto the ribbon structure of IpaD. (B) enlarged 
version of the binding pocket showing key contacts.10 (Fig 5-S1 is from Ref 10.) 
 
 156
Chapter 7: Summary of TTSA Project 
 
The type III secretion system (TTSS) is commonly utilized by many Gram-
negative bacteria to infect host cells.1; 2 Among these bacteria are human pathogens, 
which can cause a variety of infectious diseases.3 The bacterial pathogenicity is 
mediated by the disruption of normal cellular function by effector proteins, which is 
injected from the bacterium into the host cell through a TTSS mediated process.1; 3  
Although effector proteins diverge from pathogen to pathogen4; 5, the type III 
secretion apparatus (TTSA), which is the multiple-protein assembly for this protein 
secretion process, is structurally and functionally conserved.6 The TTSA is composed 
of basal body which spans both bacterial inner membrane and outer membrane, and 
the external needle topped with a tip complex that controls the secretion and delivery 
of the translocators and effector proteins. The structure and function studies of TTSA, 
especially the assembly of needle and tip complex, are necessary in understanding the 
type III secretion mechanism.6; 7 Despite an increasing body of work on the high 
resolution structures of individual proteins8; 9; 10; 11; 12; 13; 14; 15; 16, gaps in knowledge 
remain on how proteins interact and assemble.7; 8 We used NMR spectroscopy to 
study the protein structures, protein dynamics and protein-protein interactions 
involved in the assembly of TTSA needle and tip complex. 
The NMR structures of both BsaLCΔ5 and PrgICΔ5 showed a common central 
two helix bundle flanked by N- and C-terminal flexible tails.12; 13 The flexible tails 
adopt partial α-helical character with intermediate rigidity in both BsaLCΔ5 and 
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PrgICΔ5, suggesting that upon protein-protein interaction those flexible termini will 
experience structural changes and form regular α-helix.12; 13 The electrostatic surface 
potential analysis of PrgICΔ5, BsaLCΔ5 and MxiHCΔ5 showed radical differences in the 
negatively charged surfaces.12 Despite being highly acidic proteins, these proteins 
contain positively charged surfaces, suggesting electrostatic contacts are important in 
needle assembly.12 It will be interesting to determine the specific ionic strength and 
salt compositions that could disrupt needle assembly; and this exploration will not be 
limited to small molecules but also small peptides.  Modeling of the needle suggests 
that the Salmonella needle might assemble differently compared to the Shigella 
needle.12 The exact topology of Salmonella needle will require the high resolution 
structure determination of the intact needle. 
We also used the method of NMR chemical shift mapping to characterize the 
PrgI monomer-monomer interaction. Residues in various sites of PrgI were perturbed 
in the titration experiments, suggesting multiple contacts are involved in the PrgI-PrgI 
interaction. This result is consistent with the proposed model by Deane et al. that a 
needle monomer is surrounded by 7 needle monomers, indicating inter-molecule 
interactions. Many of the PrgI residues perturbed upon PrgI-PrgI titration are charged 
residues, suggesting that electrostatic interaction could be important in PrgI-PrgI 
interaction.  Some hydrophobic residues are also perturbed in the PrgI-PrgI titration, 
suggesting hydrophobic interaction might also contribute to needle assembly. 
Additionally, our NMR titration data showed a weak binding interaction between PrgI 
monomers, in the order of Kd ~ 0.7 mM. This weak binding is not surprising 
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considering that needle monomers are packed against other needle monomers in a 
super-helical fashion; and that high affinity interaction could be achieved by a high 
local needle monomer concentration.  By using truncation mutant (PrgICΔ5) or GB1-
fusion to obtain monomeric proteins for solution studies, our data, however do not tell 
the native dissociation constant among the intact needle monomers, which might be 
much higher than the affinity suggested by our data.  Further characterizations 
including fine distance restraints between needle monomers using NOE (nuclear 
Overhauser effect), RDC (residual dipolar coupling) and PRE (paramagnetic 
relaxation enchancement) restraints are needed. High resolution structural techniques 
like cryo-EM and solid-state NMR will also provide unique information on intact 
needles.  
The PrgI-SipD NMR titration data showed distinct sites in PrgI that are 
involved in the PrgI-SipD interaction, compared to the PrgI-PrgI interaction. Residues 
on the PrgI C-terminal tail were shown to be involved the PrgI-SipD interaction. 
Residues at the N-terminus were also perturbed; and this is likely due to the allosteric 
conformational change upon the PrgI-SipD interaction. Although the chemical shift 
mapping of SipD-PrgI titration did not show any obvious peak shifts, we were able to 
show tip-needle interaction using Burkholderia homologous proteins BipD and BsaL. 
After the completion of the backbone resonance assignment of BipD, the binding 
sites of BipD will be revealed upon the binding to BsaL; and this information will 
provide general knowledge on the bacterial tip-needle interaction. The weak 
interactions between bacterial needle proteins and tip proteins will be studied using 
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paramagnetic relaxation enhancement (PRE), an NMR technique that relies on the use 
of spin labels, which can identify weak protein-protein interactions. Although this 
weak needle-tip interaction might not represent the native interaction between the 
assembled needle and tip complex, further studies on how the tip proteins assemble 
into the tip complex will be characterized as well. 
Recently, binding of deoxycholate (DOC) to IpaD is suggested to be an early 
step during the activation of the type III secretion in Shigella flexneri.17 The 
availability of tip proteins that gave excellent NMR spectra indicated that the tip 
protein-DOC interactions can be studied by NMR. The titration of SipD with DOC 
showed perturbed SipD residues that were clustered into one site located at the 
bottom of the central coiled-coil and the long loop connected to the N-terminal 
domain, on the opposite side of coiled-coil where locates the N-terminal two helices. 
There are some other residues located at the loop regions, suggesting possible 
conformational changes of both the N-terminal two-helix domain and the distal 
domain. Our result is different with the proposed computer model of DOC binding to 
IpaD18, although this difference might not exclude the possibility that same activation 
mechanism upon DOC binding is used for both Shigella and Salmonella.   It was also 
found that DOC bound more tightly to IpaD compared to SipD18, thus the binding site 
ascribed to the SipD-DOC interaction might represent the weaker affinity site of 
DOC. The full NMR resonance assignments of SipD will provide a wealth of 
information not only for characterizing the tip-needle and tip-DOC interactions, but 
also open the possibility of studies addressing tip-tip and tip-translocator interactions.  
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In summary, the data in this dissertation show primary information for 
understanding the needle assembly by solving the structure of the needle protein, 
PrgI.12 Both N- and C-termini of PrgICΔ5 and BsaLCΔ5 adopt semi-rigid partial α-
helical character.12; 13 We suggested that soluble needle proteins might possess 
different structure dynamics compared to the assembled needle monomers. Our data 
also showed weak interactions were involved in the needle monomer-monomer 
interaction and needle-tip interaction. Most likely, this weak interaction arose from 
the changes made in the needle protein so it can be solubilized. Distinct binding sites 
of PrgI were involved in the PrgI-PrgI and the PrgI-SipD interactions. These weak 
interactions provide a starting point for the design the anti-bacterial agents to disrupt 
these protein-protein interactions involved in the assembly of type III secretion 
apparatus. When DOC binds to the tip protein, the tip protein is suggested to 
experience conformational changes, which will allow the further recruitment of the 
translocator protein. Studies on how the interaction between the tip protein and the 
translocator protein will provide additional structural information for further 
understanding the various stages in the maturation of the type III secretion apparatus. 
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 Chapter 8: NMR Structure Determination of the Andes Hantavirus 
Nucleocapsid Protein Coiled-coil Domain 
 
INTRODUCTION 
Hantaviruses can cause two emerging infectious diseases known as the 
hantavirus cardiopulmonary syndrome (HCPS) and the hantavirus hemorrhagic fever 
with renal syndrome.1 Annually, there are over 150,000 cases of hantaviral infections 
reported world wide.2 Rodents are the primary reservoir of hantaviruses, and humans 
are normally infected by inhalation of aerosol contaminated with the excreta of 
infected rodents. In 1993, the first reported cases of HCPS in North America3 was 
caused by a novel hantaviral species4; 5, the Sin Nombre virus, and had an initial 
mortality rate of 78%. HCPS has since been reported throughout the United States 
with a current mortality rate of 35% when correctly diagnosed.6 The major cause of 
HCPS in South America is the Andes virus, and person-to-person transmission of the 
Andes virus was reported in Argentina and Chile.7 Hantaviruses are known to invade 
and replicate primarily in endothelial cells, including the endothelium of vascular 
tissues lining the heart, without any apparent cytotoxic effect.8; 9; 10 Although the 
molecular events remain poorly understood, the decreased heart pumping capacity 
(leading to cardiogenic shock) in HCPS is not a direct result of cardiac cell death 
upon hantavirus infection.11 Hence, the myocardial depression seen in HCPS is 
hypothesized to be mediated by an unknown factor, possibly related to the immune 
response to infection12 or the release of a secondary signaling molecule involved in 
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inflammation like nitrous oxide, which was shown to be elevated during hantaviral 
infections.13; 14; 15  
The genome of hantaviruses consists of three negative-stranded RNAs 
designated as small (S), medium (M), and large (L), which encode the nucleocapsid 
(N) protein, two integral membrane glycoproteins (G1and G2), and an RNA 
dependent RNA polymerase (L protein), respectively. G1 and G2 are glycoproteins 
that form heterodimers on the viral surface. In G1 and G2, the amino termini are 
glycosylated and form the ectodomains, followed by single pass transmembrane 
helices, then the carboxy termini or cytoplasmic tails project within the virions.16 The 
G1 protein cytoplasmic tail was suggested to bind the viral RNP (ribonucleoprotein) 
and is critical for the viral assembly.16 The RNA dependent RNA polymerase (L 
protein) is believed to bind three viral RNA segments and perform transcriptase and 
replicase function. The detailed knowledge on viral assembly and viral pathogenicity 
still remains unknown. 
The N protein is highly immunogenic17; 18 and elicits a strong immune 
response, which confers protection in mice.19; 20; 21 It is highly conserved among 
hantavirus species and is the most abundant viral protein. It plays important roles in 
viral encapsidation, RNA packaging, and host-pathogen interaction.22 The N protein 
binds to viral proteins22, host proteins,23; 24; 25; 26; 27; 28; 29 and viral RNA.30; 31; 32; 33; 34 
The self-association of the N protein into trimers was shown by gradient fractionation 
and chemical cross-linking.35 Deletion mapping identified that regions at the N and C 
termini are important in N-N interaction,35; 36; 37 and a model of N protein 
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trimerization was proposed by electron microscopy data to adopt the head-to-head 
and tail-to-tail association of the N-terminal and C-terminal domains, respectively.36; 
38 The N-terminal region in the Sin Nombre virus N protein (residues 3–73)39 and the 
Tula virus (residues 1–77)40 were predicted to form coiled coil domains. Recently, the 
structure of the N-terminal coiled coil domain (residues 1–75 and1–93) of the Sin 
Nombre virus was determined by crystallography.41 
In addition to trimerization, the N protein was reported to also be involved in 
interaction with other proteins such as the viral polymerase and a viral glycoprotein22 
and host cellular proteins. The interaction between SUMO-1 (small ubiquitin-related 
modifier) and the SUMO-1 conjugating enzyme Ubc923; 25; 27 with N protein were 
reported and was required to localize the N protein in the preinuclear region.27 
Binding was mapped to the middle of the Hantaan virus N protein (residues 101-238) 
and a consensus motif of Ubc9 and SUMO-1 (with the sequence MAKE).27 Similar 
results were observed with the middle region of Seoul virus N protein. Specifically 
residues 100-125 were critical in interacting with SUMO-1 and Ubc9.25 Another 
protein that was reported to bind the N protein is the Daxx protein, a cellular protein 
primarily involved in protein-protein interactions in apoptosis and transcriptional co-
repression. The interaction was mapped to the the C-terminal 57 residues of the 
Puumala virus N protein and the C-terminal 142 residues of Daxx protein.26 The N 
protein was also reported to bind to soluble actin monomers and the insoluble 












Figure 8-1. Predicted secondary structures of the three genomic segments (S, M and 
L) of Andes virus panhandles. The first 14-nucleotides are identical in the three 
segments (shaded). 
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association between N protein and a cellular protein MxA was shown to regulate the 
interferon-inducible immune response.24  
Another function of the N protein is to bind the viral genome, which consists 
of three negative-strand RNA segments. N protein trimers bound with higher affinity 
and specificity to the viral RNA compared to monomers and dimers.32 Synthetic 
peptides corresponding to the N protein central region (residues 175-217), which 
contains a significant number of conserved lysines and arginines, bound tightly to the 
viral RNA genome by gel shift assays.34; 42; 43 The recombinant, His-tagged C-
terminal 100 residues of the Puumala virus and Hantaan virus N protein bind the viral 
RNA genome nonspecifically, with higher affinity to double-stranded over signal-
stranded RNA.30 Futher identification showed N protein bound tightly at the 5’ and 3’ 
ends of the viral RNA genome, which have complementary sequences (Fig. 8-1) and 
were predicted to fold into “panhandle”-like secondary structures. The minimal 23-
base pair viral panhandle of the Sin Nombre virus bound to the N protein with 
nanomolar affinity.33 
In this chapter, we describe the solution structure of the N-terminal 1–74 
residues of the Andes virus N protein, which forms a coiled coil domain. Further, we 
identified that the coiled coil contains distinct regions of positively and negatively 
charged surfaces involving conserved polar residues. We hypothesize that these 
regions are also important in N protein function. We used site-directed mutagenesis to 
alter the surface of the N protein and assayed for the subcellular localization of the N 
protein by immunocytochemistry. We used CD spectroscopy to confirm that 
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mutations did not alter the coiled coil structure of the N1–74 (residues 1–74 of the N 
protein) domain. However, immunocytochemistry showed that despite the N protein 
being present throughout the cytoplasm, a monoclonal antibody only recognized the 
Arg22 and Lys26 mutants when nucleocapsids are bound to the Golgi, the site of viral 
assembly and maturation. We propose that the conserved surface residues Arg22 and 
Lys26 are important in the proper conformation or molecular recognition of the N 
protein. This chapter is adapted from the published paper by Wang et al.44  
 
MATERIALS AND METHODS 
Protein Expression and Purification of N1–74 
The N1–74 domain of the Andes virus (strain 23) nucleocapsid protein was 
subcloned into pET-151 (Invitrogen), which appends a 33-residue His6 tag and a TEV 
protease cleavage site at the N terminus. Isotopically (15N/15N,13C) labeled protein 
was overexpressed in Escherichia coli BL21(DE3) (DNAY) grown in 1 liter of M9 
minimal medium with 2g [13C]glucose or/and 1g [15N]ammonium chloride. The cells 
were grown at 37°C to A600 0.8, induced with 1 mM isopropyl-β-D-
thiogalactopyranoside (IPTG), and incubated overnight (16 h) in a 15°C shaker. The 
cells were harvested by centrifugation, resuspended in 30 ml of binding buffer (20 mM 
Tris-HCl, pH 8.0, 500 mM NaCl, 5 mM imidazole), and lysed by sonication. The 
recombinant protein was purified via His6 tag as described. His6 tag was removed 
using TEV protease from purified His6- (TEV)- N1–74. The TEV cleaved protein 
sample was further purified by the Ni2+ affinity column. All the purified protein 
 169
samples were concentrated using Amicon ultracel-3k if needed and then dialyzed into 
NMR buffer (10 mM sodium phosphate, pH 6.9, 10 mM NaCl) before use and the 
protein concentration was estimated using absorbance at 280 nm.  
 
Mutagenesis of N1–74  
Site-specific mutations in the N1–74 domain were introduced by PCR using the 
Stratagene QuikChange kit in two plasmids: (i) pET-151-N1–74 (Ampr), used to 
overexpress recombinant His-tagged N1–74 in E. coli, and (ii) pcDNA3.1-AND-N 
(Ampr), used to express full-length Andes virus N protein in a mammalian cell line 




NMR data were acquired at 25°C using a Bruker Avance 800 MHz 
spectrometer equipped with a cryoprobe, processed with NMRPipe,45 and analyzed 
with NMRView.46 Backbone assignments were obtained from 2D 1H-15N HSQC47 and 
3D HNCA,48 CBCA(CO)NH,48 HNCACB,49 and HNCO (Table 8-S1).50 Secondary 
structures were identified from the Cα, Cβ, C', and Hα chemical shifts.51 Side chain 
assignments were obtained from 2D 1H-13C HMQC,52 3D HBHA(CO)NH,53 and 3D 
13C-edited HMQC-NOESY (tmix = 120 ms).54 Nuclear Overhauser effect (NOE) cross-
peaks were identified from 3D 15N-edited NOESY-HSQC (tmix = 120 ms)55 and 3D 
13C-edited HMQC-NOESY (tmix = 120 ms) (Table 8-S1).54 Hydrogen-deuterium 
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exchange was performed by lyophilizing a 600-µl 15N-labeled NMR sample and 
resuspending in 600 µl of 50% D2O, 50% H2O, followed by acquisition of six 
consecutive 20-min 2D 1H-15N HSQC spectra. Peak volumes were analyzed to 
identify residues with slower hydrogen-deuterium exchange rates. 
 
Structure Calculation 
NOE distance restraints were classified into upper bounds of 2.7, 3.5, 4.5, and 
5.5 Å and lower bound of 1.8 Å based on peak volumes. Backbone dihedral angles in 
the α-helical regions were restrained to φ(-60 ± 20°) and ϕ(-40 ± 20°). Hydrogen 
bonding distance restraints were used for -helical residues that showed slow 
hydrogen-deuterium exchange rates. Initial structures were generated by torsion angle 
dynamics in CYANA,56 followed by molecular dynamics and simulated annealing in 
AMBER7,57 first in vacuo and then with the generalized Born potential to account for 
the effect of solvent during structure calculation. Details of CYANA and AMBER 
structure calculation protocols have been described elsewhere.58 Iterative cycles of 
AMBER calculations followed by refinement of NMR-derived restraints were 
performed until the structures converged with low restraint violations and good 
statistics in the Ramachandran plot. A family of 20 lowest energy structures was 
analyzed using PROCHECK,59 and graphics were generated using PyMol.60 The 





N1–74 samples for CD spectroscopy contained 5–10 µM protein in buffer (25 
µM Tris-HCl, pH 8, 3 µM EDTA, and 5 µM dithiothreitol). CD spectra were 
collected on a Jasco J-815 spectropolarimeter in triplicate. Wavelength scans were 
collected at 25°C at a scanning rate of 50 nm/min. Thermal denaturation scans at 222 
nm were acquired with a temperature ramp rate of 1 °C/min to a final temperature of 
80 °C, followed by cooling at 1°C/min to 25°C. The melting temperature (Tm) was 
determined from calculating the first derivative of thermal denaturation plots using 
the Jasco CD software. 
Immunocytochemistry 
Immunocytochemistry was performed as reported.62 Briefly, Cos-7 cells 
(ATCC; # CRL-1651) were grown overnight in 24-well plates with coverslips at 37°C 
and 5% CO2 in Dulbecco's modified Eagle's medium containing 10% fetal bovine 
serum. The cells at 80% confluence were transfected using Lipofectamine 2000 
(Invitrogen) with 0.8 µg of pcDNA3.1-AND-N plasmid, which expresses full-length 
wild type or mutated N protein. At 48 h after transfection, the cells were washed with 
ice-cold phosphate-buffered saline and fixed at room temperature with 
methanol:acetone (3:1) for 10 min. The cells were incubated in 10 mM glycine for 30 
min and permeabilized in phosphate-buffered saline with 0.1% Triton X-100 for 30 
min. Permeabilized cells were incubated with antibodies for 60 min at room 
temperature and washed for 5 min three times with 0.3% Tween in phosphate-
buffered saline after each incubation. Goat serum (10%) was used as a blocking agent. 
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Primary antibodies were of two sets: (i) rabbit polyclonal anti-hantavirus 
nucleocapsid (1:1000) (Immunology Consultants Laboratory; No. RSNV-55) and 
mouse monoclonal anti-hantavirus-nucleocapsid (1:1000) (Abcam; No. AB34757) or 
(ii) rabbit anti-Golgi matrix protein GM130 (1:200) (Calbiochem; No. CB1008) and 
mouse-anti-hantavirus nucleocapsid (1:1000). Secondary antibodies used were Alexa-
Fluor-488 (1:1000) (Invitrogen; No. A11008) and Alexa-Fluor-594 (1:1000) 
(Invitrogen; No. A11005). Lastly, the cells were stained with 4',6-diamidino-2-
phenylindole (Bio-Genex; No. CS2010-06), mounted on slides, and visualized at 60x 
on an Olympus FV1000 confocal microscope. The images were cropped and adjusted 
using Adobe Photoshop CS2.  
 
RESULTS 
NMR Structure Determination of N1–74 
The His6-N1–74 expressed well in soluble form in E. coli and yielded an 
excellent 2D 1H-15N HSQC spectrum that showed distinct and well dispersed peaks 
(Fig. 8-2A). Nearly complete backbone assignments were obtained from 3D HNCA 
(Fig. 8-S1), CBCA(CO)NH, HNCACB (Fig. 8-S2), and 15N-edited NOESY-HSQC 
(Fig. 8-S3). The histidine residues of the His tag were overlapped and could not be 
assigned unambiguously. The Cα, Hα, Cβ, and C' secondary chemical shifts (Fig. 8-S4) 
showed that the first 33 residues, which were part of the His6 tag, were in random coil 










Figure 8-2. (A) Assigned 1H-15N HSQC spectrum of Andes virus N1-74 domain. The 
33 N-terminal residues (shown with *) are part of the His-tag introduced by pET-151. 
The boxes show expansions of the crowded regions. (B) Superposition of 20 low 
energy NMR structures of the Andes virus N1-74 coiled coil domain. N1-74 forms two 
α-helices, M1-V34 and V39-L74. The anti-nucleocapsid monoclonal antibody used in 
immunocytochemistry below recognizes an epitope somewhere between residues 1-
45.44 
 174
contained two α-helices.51 The core domain structure was not affected by the flexible 
33-residue His6 tag (Fig. 8-S5).  Side chain assignments were completed using 2D 1H-
13C HMQC (Fig. 8-S6), 3D HBHA(CO)NH, and 3D 13C-edited HMQC-NOESY. 
Manual analysis of 3D 15N- and 13C-edited NOESY spectra identified 1432 
unambiguous interproton distance restraints. The NOE restraints together with 73 φ 
and 62 ϕ dihedral angle restraints and 38 hydrogen bond restraints (Table 8-1 and Fig. 
8-S7) were used in structure calculation and refinement using CYANA and AMBER. 
The 20 lowest energy NMR structures of N1–74 converged into a family of structures 
(Fig. 8-2B) with low restraint violations and good Ramachandran plot statistics (Table 
8-1). 
 
The N1–74 Coiled Coil Domain 
N1–74 forms two well defined α-helices (α1, Met1–Val34; α2, Val39–Leu74) 
that are connected by an ordered acidic loop (Asp35-Pro36-Asp37-Asp38) (Fig. 8-
2B). The two helices are intertwined into a coiled coil, and the helix α1-α2 interface is 
lined with hydrophobic amino acids positioned in every seventh residue on helix α1 
(Leu4, Ile11, Leu18, Leu25, and Val32) and helix α2 (Leu44, Val51, Leu58, and 
Leu65) (Fig. 8-3A). This heptad repeat of hydrophobic residues is a hallmark of 
coiled coils and is highly conserved among hantaviruses.40 Together with Pro36, the 
heptad repeats of leucines, isoleucines, and valines form the hydrophobic core that 
stabilize the structure of the coiled coil (Fig. 8-4A). On the same face of the 




Figure 8-3. (A) Heptad repeats of conserved hydrophobic residues form the interface 
of the helix α1 and α2 that stabilize the coiled coil domain. (B) There is also a heptad 
repeat of polar residues, some of which (Arg22–Glu55 and Glu15–Lys62) form salt 
bridges that contribute in stabilizing the coiled coil. (C) There are many highly 
conserved residues that point away from the coiled coil and thus are not involved in 
stabilizing the coiled coil. (D) Electrostatic surface potential map of N1–74. The 
orientation of the left panel is identical to that in A and is rotated 180° from the right 
panel, which is identical in the orientation of C. Conserved surface residues forming 
the acidic (red) and basic (blue) surfaces are indicated. Point mutations of Arg22 and 
Lys26 had a dramatic effect on the antibody recognition of the N protein in vivo.44 
 
 
Table 8-1. Structural statistics for 20 NMR structures of Andes virus N1-74 coiled coil 
domain.44 
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polar residues on helix α1 (Gln8, Glu15, Arg22, and Glu29) (Fig. 8-3B), which are 
invariant among the hantaviruses (Fig. 8-S8). Helix α2 also contains a polar heptad, 
with more residue variability at positions 41 (Lys), 48 (Arg/Gln/Glu), 55 (Glu/Gln), 
and 62 (Lys/Arg). These polar residues form two conserved salt bridges between helix 
α1-α2 (Glu15–Lys62 and Arg22–Glu55) (Fig. 8-3B). Gln8 and Lys41 are surface-
exposed and do not form obvious salt bridges; however, they are invariant among the 
hantaviruses, suggesting an unknown function. 
In addition to the conserved heptad repeats mentioned above, there are other 
highly conserved residues whose side chains are pointed toward the helix α1-α2 
interface. These residues are nonpolar (Leu7 and Leu54), aromatic (His14), polar 
(Gln17, Asn40, and Thr43), or charged (Glu6, Glu15, Glu29, Lys41, Arg47, and 
Lys57), and their side chains are pointed toward the helix α1-α2 interface (Fig. 8-3C). 
The polar and charged residues in this group do not participate in any salt bridge or 
hydrogen bonding contacts; however, their polar moieties are pointed toward the 
surface of the coiled coil, whereas the aliphatic portion of their side chains are 
involved in hydrophobic interaction that contribute to the stabilization of the 
hydrophobic core. The methyl groups of two invariant alanines, Ala21 and Ala28, in 
helix α1 (Fig. 8-3C) are oriented toward the helix α1-α2 interface but do not contact 
any other residues on helix α2, indicating that small side chains are required in those 
positions. 
 
Conserved Surface Residues 
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A striking feature of the N1–74 coiled coil is the presence of large numbers of 
highly conserved residues whose side chains are pointed away from the coiled coil. 
These residues are nonpolar (Ala66 and Val19), polar (Gln8 and Gln23), basic 
(Lys24, Lys26, Arg63, and Lys73), and acidic (Asp27, Glu33, Asp35, Asp37, Asp38, 
Glu60, and Asp67) (Fig. 8-3B and 3C). These polar residues are identical (Gln8, 
Gln23, Lys24, Glu33, Asp35, Asp37, Arg63, and Lys73) or semi-identical (basic 
residues in position 26 and acidic residues in positions 27, 38, and 60) among 
hantaviruses (Fig. 8-S8). Further, many residues in this group are clustered together 
on the surface. The first cluster (Gln23, Lys24, and Lys26 together with Arg47 and 
Arg22 discussed in the preceding paragraph) forms a basic surface (Fig. 8-3D), and 
the second cluster (Asp27, Glu33, Asp35, Asp37, and Asp38) forms an acidic surface 
(Fig. 8-3D). We mutagenized many residues in this group (see below) to test the 
hypothesis that these residues are important in molecular recognition rather than in 
stabilizing the coiled coil structure. 
 
Electrostatic Surface of N1–74 
The N1–74 domain is acidic (theoretical pI of 5.8), and the surface electrostatic 
potential map of N1–74 shows distinct regions of negatively charged (red) and 
positively charged (blue) surfaces (Fig. 8-3D). The tip of the coiled coil, where the 
loop connecting the two helices is located, is negatively charged (Fig. 8-3D) because 
of clustering of conserved acidic residues (Asp27, Glu29, Glu33, Asp35, Asp37, and 




Figure 8-4. (A) CD spectra of N1–74 wild type (WT) and point mutants (K26E and 
R22F) showing the characteristic α-helical dips at 208 and 222 nm. All other N1–74 
point mutants (listed in Table 8-2) showed similar α-helical CD spectra. (B) CD 
thermal denaturation curves, monitored at 222 nm, of wild type N1–74 and two point 
mutants, K26E and R22F. The rest of the point mutants showed similar thermal 
denaturation curves. The ellipticity scales on the y axes are shown on left (wild type 





Table 8-2. Melting temperatures (Tm) and ellipticity (θ) ration at 222 and 208 nm of 





there are conserved basic residues (Arg22, Lys24, Lys26 and Arg47) that form a 
positively charged surface just below the negatively charged tip (Fig. 8-3D). Point 
mutations in this positively charged surface have a dramatic effect on the antibody 
recognition of the N protein in vivo (see below). 
In addition, there is a smaller negatively charged surface formed by Glu9 and 
Glu6 (Fig. 8-3D). Residue 9 could be acidic (Glu or Asp) or basic (Arg or Lys). 
Residue 9 is acidic among American hantaviruses (which cause the cardiopulmonary 
syndrome) and Old World hantaviruses that are nonpathogenic or cause a milder form  
of hemorrhagic fever with renal syndrome. Residue 9 is basic among Old World 
hantaviruses that causes the severe form of hemorrhagic fever with renal syndrome. 
 
CD Spectroscopy of N1–74 
Point mutations were introduced in the basic (Arg22, Lys24, Lys26, and 
Arg47) and acidic (Glu33 and Asp38) surfaces. In addition, we mutated Gln23, which 
is near the basic region, and Pro36, which is near the acidic region. These residues are 
surface-exposed (Fig. 8-3D) and are nearly invariant among hantaviruses (Fig. 8-S8). 
CD spectroscopy was used to assess the folding and stability of N1–74 mutants. Wild 
type and point mutants showed nearly identical CD spectra (Fig. 8-4A), indicating 
that the -helical structure of N1–74 was preserved. In addition, the ratio of ellipticity at 
222 and 208 nm can be used to characterize -helices. A θ222/θ208 ratio of 1.0 
indicates α-helices with extensive interhelical contacts as in coiled coils and helical 




Figure 8-5. Immunocytochemistry of full-length N protein with point mutations in 
the N1–74 coiled coil domain. Cos-7 cells were transfected with a plasmid expressing 
Andes virus N protein. Two days after transfection, the cells were fixed for 
immunofluorescence microscopy and double labeled with monoclonal (red) and 
polyclonal (green) anti-nucleocapsid antibodies (A) and monoclonal anti-
nucleocapsid antibody (red) and anti-Golgi antibody (green) (B). The cell nuclei were 
stained blue using 4',6-diamidino-2-phenylindole. Point mutations in Arg22 and 
Lys26 showed a dramatic difference in the monoclonal antibody recognition of 
Golgi-associated N protein, suggesting that the conformation or molecular interaction 
(or both) of the N protein is different when it is in the cytoplasm or when it is 
associated with the Golgi. WT, wild type.44 (Data courtesy of Daniel M. Boudreaux 
from Dr. Stephen C. St. Jeor, University of Nevada, Reno) 
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interhelical contacts.63; 64; 65 All N1–74 constructs have a θ222/θ208 ratio higher than 0.9 
(Table 8-2), suggesting that all mutants have the intact coiled coil structure. Further 
insight was provided by acquiring the CD melting temperatures (Fig. 8-4B and Table 
8-2). Compared with wild type N1–74, the majority of mutants showed lower Tm, with 
D38R having the lowest value, whereas two mutants (K24A and R47A) showed 
higher Tm (Table 8-2). Nevertheless, all mutations were within ±5°C of  wild type Tm 
(Table 8-2), indicating that the mutations did not drastically alter the thermal stability 
of N1–74. Thus, the point mutations maintained the structural integrity of the N1–74 
coiled-coil. 
 
Immunocytochemistry of N Protein 
Hantaviruses are believed to mature intracellularly; specifically, in the Golgi 
complex.66 During infection, the N protein was shown to localize cytoplasmically in 
the endoplasmic reticulum-Golgi intermediate compartment, presumably as they 
traffic from the endoplasmic reticulum to the Golgi.28 In addition, 
immunofluorescence of Cos-7 cells transfected with the N protein alone showed a 
granular pattern of staining in the perinuclear region,38; 40 suggesting colocalization 
with the Golgi. To test our hypothesis that the conserved surface residues of N1–74 are 
important in molecular interaction, we introduced point mutations designed to keep 
the N1–74 coiled-coil domain intact while altering only specific surface residues and 
transfected full-length N protein in mammalian cells to observe the subcellular 
localization of the N protein. Immunocytochemistry was performed by Daniel M. 
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Bourdreaux in the laboratory of Dr. Stephen C. St. Joer at the University of Nevada, 
Reno. Two types of anti-nucleocapsid antibodies, rabbit polyclonal and mouse 
monoclonal antibodies were used. The polyclonal antibody detected that wild type N 
and mutants (Arg22, Gln23, Lys24, and Lys26) were located throughout the 
cytoplasm (Fig. 8-5A). The monoclonal antibody also detected wild type N and the 
Gln23 and Lys24 mutants throughout the cytoplasm in a similar pattern of staining as 
the polyclonal antibody (Fig. 8-5A). However, the monoclonal antibody showed a 
dramatic difference between the recognition of wild type N and the Arg22 and Lys26 
mutants (Fig. 8-5A). Using the monoclonal antibody, Arg22 and Lys26 mutants were 
observed in a compact location lateral to the nucleus (Fig. 8-5A). To further define 
the subcellular localization of these N mutants, a Golgi-specific antibody (targeting 
the Golgi matrix protein GM130) was used (Fig. 8-5B). The Arg22 and Lys26 
mutants were only detected by the monoclonal antibody when the N protein 
colocalized with the Golgi (Fig. 8-5B); however, these mutants were also present 
throughout the cytoplasm as shown by the polyclonal antibody (Fig. 8-5A). Thus, for 
the Arg22 and Lys26 mutants, the monoclonal antibody was able to distinguish 
between two populations of the N protein based on its subcellular localization in the 
cytoplasm or in the Golgi, the site of viral assembly and maturation.66 Other mutants 
(Glu33, Asp35, Pro36, Asp37, Asp38, and Arg47) did not show this localization-





The NMR structure of the Andes virus N1–74 domain is similar to the recent 
crystal structure of the Sin Nombre virus nucleocapsid protein N-terminal coiled-coil 
(N1–75).41 The Cα root mean square deviation (RMSD) between the two structures is 
1.3 Å. The crystal structure determination of the N protein addressed the issue of the 
trimerization of the N protein41 because earlier models suggested the trimerization of 
the nucleocapsid N-terminal domain.35; 36; 38; 39 A proposed model of N protein 
trimerization involves, first, the association of three N-terminal domains, followed by 
the association of three C-terminal domain.40 However, crystallography revealed that 
the Sin Nombre nucleocapsid N-terminal domain was monomeric and formed a 
coiled-coil structure, and conserved hydrophobic residues participate in helix-helix 
interaction that stabilize the coiled-coil.41 Our NMR structure of the Andes virus N1–74 
supports the crystallographic results; even at 1.4 mM, N1–74 remained monomeric in 
solution. Our results, however, do not preclude the trimerization of full-length N 
protein in vivo by another mechanism.  
A feature of the N1–74 domain that had not been addressed in the literature is 
the role of many conserved polar residues whose side chains are pointed away from 
the coiled-coil. Furthermore, the majority of these surface-exposed residues are not 
involved in polar interactions (Fig. 8-3D). Point mutations of these polar residues 
maintained the structural integrity and high thermal stability of the coiled-coil (Fig. 8-
4 and Table 8-2). For example, Arg22, which forms a salt bridge with a conserved 
residue Glu55, can be mutated (R22F or R22M) without disrupting the coiledc-coil 
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structure of N1–74 (Table 8-2). R22F, which replaced arginine with a bulkier aromatic 
side chain, decreased the overall melting temperature by ~3°C (Table 8-2). This 
change is likely attributed to increased steric clash between phenylalanine and Glu55. 
However, the observation that R22M melts at a temperature comparable with that of 
wild type suggests that the salt bridge between Arg22 and Glu55 does not play a 
significant role in helix-helix interaction and that hydrophobic interaction is the major 
force stabilizing the coiled-coil. A mutation in a nonpolar residue, Pro36, which is at 
the turn connecting the two α-helices of the coiled-coil, had a Tm approximately four 
degrees lower than wild type, which is consistent with a mutation that increases the 
number of conformations available at the Pro36 turn and destabilizes the overall 
protein structure by uncoupling the helix-helix interaction. Nevertheless, all of the 
point mutations of the conserved surface residues maintained the coiled-coil structure 
of N1–74 (Fig. 8-4 and Table 8-2).  
Thus, there is no compelling structural reason for the high sequence 
conservation of surface residues. Furthermore, these polar residues are clustered 
together on the surface of the N1–74 domain and form distinct positively and 
negatively charged regions (Fig. 8-3D). We hypothesize that the reason for the 
clustering of conserved polar residues on the surface of N1–74 is that they are sites of 
molecular recognition involved in the proper function of the N protein. Our 
mutagenesis and immunocytochemistry data suggest that point mutations in this group 
had a dramatic effect on the antibody recognition of the N protein with respect to its 
subcellular localization (Fig. 8-5).  
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During infection, nucleocapsids are trafficked to the cytoplasm28 to assemble 
into mature virions.66 Mammalian cells transfected with the N protein alone show a 
granular pattern of immunofluorescence.38; 40 This localization pattern is thought to be 
necessary for the nucleocapsid to perform its many functions in the establishment of 
an effective infection.28 We questioned whether the conserved polar surface residues 
in the coiled-coil domain are important in the proper functioning of the N protein and 
reasoned that defects in the conformation or molecular recognition of the N protein 
will be manifested in the antibody recognition of the N protein in the context of its 
subcellular localization. CD spectroscopy confirmed that the mutant forms of N1–74 
maintained the structural integrity of the coiled-coil structure (Fig. 8-4 and Table 8-2); 
thus, the mutations altered only the surface property of the N protein.  
Immunocytochemistry (Fig. 8-5) indicates that mutations in a conserved basic 
surface formed by Arg22 and Lys26 show monoclonal antibody recognition 
depending on the subcellular localization of the N protein. Polyclonal antibodies show 
that Arg22 and Lys26 mutants are present in the cytoplasm and Golgi; however, only 
Golgi-associated mutant nucleocapsids are detected by the monoclonal antibody (Fig. 
8-5). Mutation of Arg22 or Lys26 changes the presentation of the N-terminal coiled-
coil to the monoclonal antibody. This change is dependent on the subcellular 
localization of the N protein.  
There are two possible scenarios that could account for this differential 
monoclonal antibody recognition of the Arg22 and Lys26 mutants. First, there may be 
a difference in the conformation of the N-terminal coiled-coil depending on whether 
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the N protein is localized in the cytoplasm or in the Golgi, and this conformational 
change upon binding to the Golgi exposes the epitope, which is somewhere between 
residues 1–45 (comprising helix α1, the interhelical loop, and part of helix α2 of the 
N1–74 coiled-coil; Fig. 8-2B), thereby allowing the monoclonal antibody to recognize 
the N protein associated with the Golgi. Second, the epitope may be masked 
differently by molecular interactions when the N protein is localized in the cytoplasm 
or in the Golgi. In addition to self-association, several host proteins such as SUMO-
1,23; 25; 27 Ubc9,25; 27 Daxx26 actin,29 microtubules,28 and MxA24 were reported to bind 
the N protein. Binding of the N protein with SUMO-1 and Ubc9 was required for 
localization of the N protein in the perinuclear region.23; 27 Furthermore, because the 
N protein is not known to be a membrane protein, its localization in the Golgi must 
involve interaction with a Golgi-associated protein. Any of these molecular 
interactions could potentially alter the epitope presentation of the N1–74 coiled-coil and 
needs to be experimentally verified.  
In summary, our structural results revealed that the highly conserved polar 
residues in the N-terminal coiled-coil domain of the hantavirus nucleocapsid protein 
form distinct acidic and basic surfaces, and point mutations of the conserved basic 
surface formed by Arg22 and Lys26 allowed a monoclonal antibody to distinguish 
between two populations of the N protein based on its subcellular localization. Thus, 
in the Arg22 or Lys26 mutants, the conformation or molecular interaction of the N 
protein is different when it is in the cytoplasm or in the Golgi, the site of viral 
assembly and maturation. It is worth determining whether the Arg22 or Lys26 
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mutants affect the N protein trimerization or even the viral assembly. Similar to N-
terminal, C-terminal of N protein was also mapped to be important for trimerization.38 
Further information on the atomic structure of C-terminal region and how the C-
terminal is involved in the protein-protein interaction will be interesting to pursuit. 
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2D HSQC hsqcfpf3gpphwg 8 NS* 2048×128 (N) pts 20 min
2D HMQC blhmqcnoesy2d 8 NS 2048×256 (C) pts 1h 
30min 
3D HNCA hncagpwg3d 8 NS 2048×50(N)×100(C)  pts 13h 
3D CBCA(CO)NH cbcaconhgpwg3d 8 NS 2048×50(N)×100(C)  pts 14h 
3D HNCO hncogpwg3d 16 NS 2048×50(N)×50(C)  pts 7h 
3D HNCACB hncacbgpwg3d 32 NS 2048×50(N)×100 (C) pts 2d 6h 
3D HBHA(CO)NH hbhaconhgpwg3d 12 NS 2048×50(N)×96(H)  pts 19.5h 
3D HSQC-NOESY noesyhsqcf3gp193d 8 NS 2048×50(N)×256(H)  pts 1d 14h 
3D HMQC-
NOESY 
blhmqcnoesy3d 8 NS 2048×76(C)×248(H)  pts 2d 14h 
 
NS*: number of scans 





Figure 8-S1. Portion of the 3D HNCA strips of 13C, 15N-labeled 107-residue protein 
(His6-N1-74), shown as 13C, 1H strips for Val32-Asp35 (the 15N ppm is on the Z-axis). 
Each strip shows the Cα of the preceeding and current residue and the amide (1H and 
15N) resonances of the current residue, indicating sequence specific connectivity 
between these strips. The HNCA data is used together with 15N-HSQC-NOESY, 








Figure 8-S2. Portion of the 3D HNCACB strips of 13C, 15N-labeled 107-residue 
protein (His6-N1-74), shown as 13C, 1H strips for Val32-Asp35 (the 15N ppm is on the 
Z-axis). Each strip shows the Cα and Cβ of the preceeding and current residue and the 
amide (1H and 15N) resonances of the current residue, indicating sequence specific 




Figure 8-S3. Portion of the 3D 15N-HSQC-NOESY strips of 15N-labeled 107-residue 
protein (His6-N1-74), shown as 1H, HN strips for Val32-Asp35 (the 15N ppm is on the 
Z-axis). Each strip shows all the backbone HN NOE peaks including its own HN and 
the HNs of the preceding and following residues, indicating a sequence specific 






Figure 8-S4. Secondary Cα, Hα, C’, and Cβ chemical shifts show that the first 33 
residues (shaded), which are the His-tag from pET151, lack secondary structure 








Figure 8-S5. Overlay of two 2D HSQC spectra of 15N-His6-N1-74 and the TEV-
digested 15N-N1-74. Most of the peaks are overlapped, indicating the extra His6 did not 








Figure 8-S6. 1H, 13C-HMQC 2D spectra of 13C, 15N-labeled 107-residue protein 
(His6-N1-74) in 100% D2O. The 3D 13C-HMQC-NOESY experiment was based on this 
2D HMQC experiment and a third 1H NOE dimension was added. With the help of 
backbone assignment and 3D HBHA(CO)NH, complete assignment of 2D 1H, 13C-












Figure 8-S7. Overlay of two His6-N1-74 HSQC spectra showing the hydrogen-
deuterium exchange experiment. Residues I11, A21, R22, V51, E55, G59 and R63 
with slower hydrogen-deuterium exchange rate were pointed out to show the typical 
volume differences due to the protection of hydrogen bonds in α-helices. HSQC of 
black peaks was acquired at 5 mins after dissolved in 50% H2O/50% D2O; HSQC of 















Figure 8-S8. Sequence alignment of hantavirus nucleocapsid N1-74 coiled-coil domain 
with the conserved hydrophobic (gray) and polar (yellow) heptads highlighted. The 
sequences are arranged according to hantaviral species that cause: (top) HCPS 
(Hantavirus CardioPulmonary Syndrome), (middle) nonpathogenic or mild form of 
HFRS (Hemorrhagic Fever with Renal Syndrome) and (bottom) severe form of 
HFRS. The hantavirus species are: AND, Andes; SNV, Sin Nombre; LAN, Laguna 
Negra; MUL, Muleshoe; BAY, Bayou; RIO, Rio Mamore; ELM, El Moro Canyon; 
NYV, New York; TUL, Tula; ISL, Isla Vista; PHV, Prospect Hill; PUU, Puumala; 









Figure 8-S9. Immunocytochemistry of full length N protein with mutations in the N1-
74 coiled-coil domain. Cos-7 cells were transfected with will type and mutant N 
protein, and doubly stained with (A) monoclonal and polyclonal anti-N antibodies, 
and (B) monoclonal anti-N and Golgi-specific antibodies. The anti-N monoclonal 
antibody was AB34757 from Abcam (Cambridge, Mass.).44 (Data courtesy of Daniel 
M. Boudreaux from Dr. Stephen C. St. Joer, University of Nevada, Reno) 
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